<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30916138</article-id><article-id pub-id-type="pmc">6436772</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0347</article-id><article-categories><subj-group subj-group-type="heading"><subject>Guideline</subject></subj-group></article-categories><title-group><article-title>The Brazilian Society for Cardiovascular Surgery (SBCCV) and
Brazilian Society for Extracorporeal Circulation (SBCEC) Standards and
Guidelines for Perfusion Practice</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5545-8172</contrib-id><name><surname>Caneo</surname><given-names>Luiz Fernando</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Matte</surname><given-names>Gregory</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>CCP, LP, FPP</role></contrib><contrib contrib-type="author"><name><surname>Groom</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>PhD</role></contrib><contrib contrib-type="author"><name><surname>Neirotti</surname><given-names>Rodolfo A.</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>MD, PhD, FEACTS</role></contrib><contrib contrib-type="author"><name><surname>P&#x000ea;go-Fernandes</surname><given-names>Paulo Manuel</given-names></name><xref ref-type="aff" rid="aff5">5</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Mejia</surname><given-names>Juan Alberto C.</given-names></name><xref ref-type="aff" rid="aff6">6</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Figueira</surname><given-names>Fernando Augusto Marinho dos Santos</given-names></name><xref ref-type="aff" rid="aff7">7</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>de Carvalho Filho</surname><given-names>&#x000c9;lio Barreto</given-names></name><xref ref-type="aff" rid="aff8">8</xref><role>MSc</role></contrib><contrib contrib-type="author"><name><surname>da Costa</surname><given-names>F&#x000e1;bio Murilo</given-names></name><xref ref-type="aff" rid="aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Chalegre</surname><given-names>Sintya Tertuliano</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref><role>MSc</role></contrib><contrib contrib-type="author"><name><surname>Kalil</surname><given-names>Renato Abdala Karam</given-names></name><xref ref-type="aff" rid="aff11">11</xref><role>MD, MSc, PhD</role></contrib><contrib contrib-type="author"><name><surname>Almeida</surname><given-names>Rui M. S.</given-names></name><xref ref-type="aff" rid="aff12">12</xref><role>MD, MSc, PhD</role></contrib><contrib contrib-type="author"><collab>DECAM/SBCCV</collab><xref ref-type="aff" rid="aff13">13</xref></contrib><contrib contrib-type="author"><collab>SBCECV</collab><xref ref-type="aff" rid="aff14">14</xref></contrib></contrib-group><aff id="aff1">
<label>1</label> Cardiovascular Surgery Division, Instituto do
Cora&#x000e7;&#x000e3;o, Hospital das Cl&#x000ed;nicas da Faculdade de Medicina da
Universidade de S&#x000e3;o Paulo (InCor-HCFMUSP), S&#x000e3;o Paulo, SP,
Brazil.</aff><aff id="aff2">
<label>2</label> Department of Cardiac Surgery, Boston Children's Hospital, Boston,
MA, USA.</aff><aff id="aff3">
<label>3</label> Maine Medical Partners - Cardiothoracic Surgery, Portland,
USA.</aff><aff id="aff4">
<label>4</label> Clinical Professor of Surgery and Pediatrics, Emeritus Michigan
State University, MI, USA.</aff><aff id="aff5">
<label>5</label> Thoracic Surgery Division of the Instituto do
Cora&#x000e7;&#x000e3;o, Hospital das Cl&#x000ed;nicas da Faculdade de Medicina da
Universidade de S&#x000e3;o Paulo (InCor-HCFMUSP), S&#x000e3;o Paulo, SP,
Brazil.</aff><aff id="aff6">
<label>6</label> Unidade de Transplante e Insufici&#x000ea;ncia Card&#x000ed;aca do
Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, CE, Brazil.</aff><aff id="aff7">
<label>7</label> Instituto de Medicina Integral Professor Fernando Figueira (IMIP),
Recife, PE, Brazil.</aff><aff id="aff8">
<label>8</label> Universidade Estadual de Campinas (Unicamp), Campinas, SP,
Brazil.</aff><aff id="aff9">
<label>9</label> Pronto-Socorro Cardiol&#x000f3;gico de Pernambuco, (PROCAPE),
Recife, PE, Brazil.</aff><aff id="aff10">
<label>10</label> Universidade de Pernambuco (UPE), Recife, PE, Brazil.</aff><aff id="aff11">
<label>11</label> Instituto de Cardiologia do Rio Grande do Sul -
Funda&#x000e7;&#x000e3;o Universit&#x000e1;ria de Cardiologia, Porto Alegre, RS,
Brazil.</aff><aff id="aff12">
<label>12</label> Universidade Estadual do Oeste do Paran&#x000e1; (UNIOESTE),
Cascavel, PR, Brazil.</aff><aff id="aff13">
<label>13</label> Departamento de Assist&#x000ea;ncia Circulat&#x000f3;ria
Mec&#x000e2;nica (DECAM) da Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV),
S&#x000e3;o Paulo, SP, Brazil.</aff><aff id="aff14">
<label>14</label> Sociedade Brasileira de Circula&#x000e7;&#x000e3;o
Extracorp&#x000f3;rea (SBCEC), S&#x000e3;o Paulo, SP, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: <bold>Luiz Fernando Caneo</bold>,
https://orcid.org/0000-0001-5545-8172, Instituto do Cora&#x000e7;&#x000e3;o do
Hospital das Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de
S&#x000e3;o Paulo (InCor-HCFMUSP) - Pediatric Cardiac Surgery Unit, Av. Dr. Eneas
de Carvalho Aguiar, 44 - Bloco II, 2&#x000b0; andar, sala 5 - S&#x000e3;o Paulo, SP,
Brazil, Zip code: 05403-900. E-mail:
<email>luiz.caneo@incor.usp.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2019</year></pub-date><volume>34</volume><issue>2</issue><fpage>239</fpage><lpage>260</lpage><history><date date-type="received"><day>30</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>30</day><month>10</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions></article-meta></front><body><p>A primary role for clinical medicine societies is to develop standards and guidelines for
practice as an instrument to promote safe and effective patient care. The Brazilian
Society for Cardiovascular Surgery (SBCCV) represented by its Department for Mechanical
Circulatory Assistance (DECAM) and the the Brazilian Society for Extracorporeal
Circulation (SBCEC) conducted a careful critical review of current clinical perfusion
practices in Brazil. In addition, a literature review focused on patient safety and
surgical outcomes in cardiac surgery was performed. This is the first joint initiative
of these two societies (SBCCV/SBCEC) to provide a framework for safe and effective
clinical perfusion practice for our cardiac surgery patients. The purpose of this
pioneering work was to develop guidelines for the perfusion profession and for those
involved in cardiopulmonary bypass (CPB) technology in our country. Both the SBCCV and
the SBCEC recommend that institutions and clinical teams adopt the standards and
guidelines outlined in this text. The standards and guidelines we recommend are based on
those published by the published American Society for Extracorporeal Technology (AmSECT)
with a phased adoption recommendation set as an achievable goal. Further, we recommend
that cardiac surgery programs develop institution-specific protocols to support the
clinical use of these guidelines.</p><sec><title>The Pioneering Era of Cardiac Surgery</title><p>Open heart surgery has developed considerably over the past several decades including
numerous pioneering efforts in Brazil regarding biomedical engineering and
circulatory support<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Pioneer
surgeons, such as John Kirklin, Francis Fontan, Euryclides Zerbini, Adib Jatene, and
Denton Cooley were part of our lives and we were able to study their papers, witness
their presentations and participate in professional discussions. They are passing
away one after another but their work, techniques, experience and wisdom stays with
us as their legacy. The impact of their methods profoundly changed the lives of our
patients with congenital heart defects, giving them the chance of enjoying a better
quality of life. Now, the pioneering era of cardiac surgery has essentially ended in
Brazil.</p><p>Congenital cardiac surgery is markedly changing and surgeon-centered outcomes are
being replaced by team-based efforts with new paradigms requiring an adaptive work
environment in institutions where cardiac surgery is performed.</p><p>As William Norwood aptly put in his paper, <italic>Our Roots, Our Future</italic>
<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>, "Institutions are not what they are by historical
prerogative: the people walking the halls are responsible for maintaining the legacy
and creating new vistas." That being said, we need to continue the initial work of
our pioneers and press on upgrading their achievements to ever higher standards. The
era we have now entered is no longer about quantity, it is about achieving excellent
whole-patient quality outcomes including optimized neurologic outcomes. We must dig
deep into issues that impact the quality of outcomes, teamwork and overall
transparency in our respective professions.</p></sec><sec><title>Reviewing Perfusion Practice: Time to Stop Living in the Past</title><p>Brazil has a strong history of innovation that extends back to the earliest days of
cardiac surgery when our centers pioneered advances in heart-lung machines (HLMs),
cardiac valves, conduit implants, and surgical techniques. Brazil started to produce
their own HLMs in 1959 and indeed used one of them to perform the first heart
transplantation in South America. These innovations highlighted the teamwork
primarily of surgeons and biomedical engineers. This was natural since surgeons and
other physicians were the first 'perfusionists'. Additionally, perfusion products,
including a series of oxygenators, were developed and manufactured domestically.
While we fondly remember these great achievements, we also need to focus on the
future. Unfortunately, there are still people living in the past and not adapting to
evolving cardiac surgery and perfusion practices. We continue to blame our economic
burden for the stagnation of our practice while paying little to no attention to the
need for cultural change in the operating room.</p><p>Furthermore, clinical perfusion has not been recognized by the government as a
distinctive profession until quite recently. Currently, only five professional
councils recognize Perfusion as a specialty for their undergraduates: Biology,
Biomedicine, Nursing, Pharmacy, and Physiotherapy. These professions do not have a
standardized perfusion-specific curriculum. Consequently, perfusionist education and
training is heterogenous. Furthermore, it is still the case in Brazil that
perfusionists must follow the instructions of surgeons and anesthesiologists. In
fact, the conduct of perfusion is only considered a medical act once the perfusion
record is signed by the surgeon. This practice risks perfusionists not taking full
ownership for the conduct of CPB and that raises serious safety concerns since the
surgeon and anesthesiologist have much to attend to during cardiac surgery and the
perfusionist is the individual who can best manage extracorporeal support with all
of its nuances. These facts support the outdated paradigm whereby perfusionists are
essentially asked to follow the instructions of surgeons and anesthesiologists
during CPB instead of working collaboratively within a famework of well-developed
perfusion practice guidelines. Currently, the SBCEC and the SBCCV are in discussion
with the Federal Councils regarding ways for this activity to be uniformly
recognized by the Professions and subsequently legalized with a federal law
regulating perfusion activities. Brazilian perfusionists must have the education,
tools and authority to perform their job and to become active and respected members
of the multidisciplinary cardiac surgery team. Several limitations currently exist
which impair the advancement of perfusion practice, including educational gaps, a
lack of case ownership, and a lack of tools to assess the adequacy of perfusion in
real time during surgery. This is a vicious cycle which impacts outcomes and patient
safety.</p><p>On a positive note, it is important to highlight the progress made by the Brazilian
Society of Extracorporeal Circulation. Supported and stimulated by their society, a
significant number of Brazilian perfusionists have had the opportunity to attend
symposium-based perfusion related courses, exchange experiences with more advanced
international programs and to discuss current techniques of extracorporeal
circulation with local perfusionists and those from abroad.</p><p>In more developed countries, perfusionists have the freedom to choose perfusion
products according their performance, their patient population's needs, and the
information available in the literature. Each component is selected via an
independent decision with the ideal components used to build the circuit.
Alternatively, in Brazilian perfusion practice, it is difficult to be objective
since product decisions are almost exclusively based on price and subjective
preferences due to the lack of scientific publications comparing Brazilian perfusion
products with those available in other markets. In our country, oxygenator
manufacturers typically provide complimentary HLMs with an agreement that their
oxygenator can only be guaranteed on their HLM. There is an obvious conflict of
interest with such an agreement. This implied agreement has no scientific basis and,
to our knowledge, is not practiced elsewhere which speaks to the need for change in
Brazilian cardiac surgery. Again, our culture needs to adapt to end such practices
for the benefit of our patients. This is even more of a concern when one notes that
the majority of HLMs made and used in Brazil do not have servoregulating safety
devices incorporated for arterial flow, cardioplegia delivery, level sensing, and
bubble detectors. Servoregulation for HLM functions is not enough. Perfusionists
must also be trained to operate the devices. Standards for perfusion practice,
including the use of safety devices, must be established and adhered to.</p></sec><sec><title>Why are Clinical Perfusion Standards so Important?</title><p>The Gritten Report<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup> published by
the University Hospitals of Bristol National Health Service (NHS) Foundation Trust
of Great Britain described the death of a five-month-old infant undergoing complex
cardiac surgery and was released May 25, 2005. The Root Cause Analysis (RCA) report
was led by Mark Gritten, an independent and nationally known NHS senior
professional. A police investigation and coroner's inquest labeled the case
'unlawful killing'. In English law, unlawful killing means that the killing was made
without lawful excuse and in violation of criminal law including murder,
manslaughter, and infanticide. The finding of unlawful killing must be beyond
reasonable doubt; that is, the evidence must be overwhelmingly obvious that death
would result from the act when all factors are taken into account. Otherwise, a
verdict of accidental death or death by misadventure would apply. The death was the
result of a calcium overdose by a perfusionist that caused irreversible brain damage
and subsequent death the day after surgery. The hospital put safeguards into place
immediately to minimize any similar incidents happening again. Also, the National
Society of Perfusionists perhaps carried some responsibility for this incident
because it does not appear to have disseminated other perfusion incidents between
its members.</p><p>The report concluded that this was a unique but avoidable incident that resulted in
an indictment not just to the perfusionist involved in the accident, but to all
perfusionists and the perfusion profession as a whole in Great Britain. Had a
similar incident happened in S&#x000e3;o Paulo or Rio or elsewhere in Brazil, would
the SBCEC or SBCCV also be held responsible?</p><p>Perfusion practice during cardiovascular surgery is recognized in the international
literature as a critical component to successful patient outcomes. Therefore, as
medical societies, we have the responsibility to change our culture, our commercial
practices, legislation, regulations and whatever else which involves our specialty
which can improve patient outcomes<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>]</sup>. The intent of our
proposed standards and guidelines document is to provide a modern framework for the
practice of cardiopulmonary bypass in Brazil that can maximize patient safety and
outcomes.</p><p>The standards and guidelines document we developed for perfusion practice in Brazil
is based on publications from AmSECT<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup>. It focuses on the
role of written institutional protocols to dictate clinical practice. We worked on
four main subjects:</p><p>
<list list-type="alpha-lower"><list-item><p>empowerment of perfusion as profession with a focus on professional
qualification and education standards</p></list-item><list-item><p>standardization of perfusion practices</p></list-item><list-item><p>mandatory safety devices</p></list-item><list-item><p>importance of non-technical skills and patient centered team work</p></list-item></list>
</p></sec><sec><title>Professional Constraints:</title><p>Although perfusion is considered a medical act, Perfusion as a profession is still
not fully regulated in Brazil. Consequently, the legal responsibility for what
happens at the pump is unclear. The surgeon's knowledge of what is actually
happening on the pump at all times during an operation depends upon their
communications with the perfusionist. The surgeon's signature on the perfusion
record is a formality which does not ensure proper care during CPB. This practice
jeopardizes the development of a new generation of perfusionists who should be
taking ownership for their individual perfusion cases and, of course, introducing
the necessary changes to modernize existing clinical practices. The Perfusionist
must be responsible for the whole procedure of extracorporeal circulation and be an
active member of the cardiac surgery team, as is the case with most enters
abroad.</p><p>According to the SBCEC, perfusionists are expected to have:</p><p>
<list list-type="alpha-lower"><list-item><p>Dedication to the patient</p></list-item><list-item><p>Full integration with the team in which they work</p></list-item><list-item><p>Professional competence</p></list-item><list-item><p>Personal ethical and professional conduct, as well as being zealous,
affable, aware and observant.</p></list-item></list>
</p><p>Considering our context, the effort of publishing this document by the societies
SBCCV and SBCEC should be considered as one of most important steps for the future
of cardiopulmonary bypass practice in Brazil.</p><p>The "holy trinity" for the cardiac surgey patient- perfusionist, surgeon and
anesthesist- is a critical issue for optimal outcomes in cardiac surgery. Therefore,
publication in Brazil of the Standards and Guidelines for Perfusion Practice aims
not only to improve CPB but also to improve overall surgical outcomes as an
important quality improvment initiative.</p></sec><sec><title>Perfusion and the Pediatric Cardiac Surgery:</title><p>In the early 1950s, the pioneers of congenital cardiac surgery, among them- Bigelow,
Lewis, Kirklin, Gibbon and others- realized that the time available with hypothermia
and inflow occlusion would not be sufficient to safely perform lenghty intracardiac
operations and that an extracorporeal support system would be needed. In 1954,
Lillehei introduced the technique of controlled cross-circulation, in which a
patient's parent functioned as the extracorporeal pump and oxygenator- a system that
put both the parent and the child at risk. Therefore, the development of mechanical
cardiopulmonary bypass circuits in the late 1950s was an important step for the
progress of congenital cardiac surgery. Since then, extracorporeal perfusion
circuits have come a long way to the current low prime membrane oxygenators, the use
of centrifugal pumps, vacuum-assisted venous drainage, electronic gas blenders,
in-line oxygen analyzers and other important devices.</p><p>The array and complexity of the equipment, the perfusion techniques to manage a wide
variety of patient's age and size along with the broad spectrum of surgical
procedures are real challenges that require properly trained and knowledgeable
perfusionists.</p><p>Because one size does not fit all, the need for a standalone Standards and Guidelines
document to perform perfusion for congenital heart surgery is unquestionable and it
will in many ways be unique as compared to the one used for the correction of
acquired heart disease in adults.</p><p>Providing cardiopulmonary support for repair of congenital heart lesions has become a
specialty standing on its own. This context should determine the strategies and
processes to address these issues; the professionals, administrators, and
professional societies should be engaged in planning, setting and articulating the
goals of robust pediatric perfusion standards and guidelines to improve the outcomes
in pediatric cardiac surgery.</p><p>The Brazilian Society for Cardiovascular Surgery (SBCCV) and the Brazilian Society
for Extracorporeal Circulation (SBCEC) Standards and Guidelines for Perfusion
Practice address perfusion in general. We believe that developing a specific
Brazilian Pediatric Perfusion Standards and Guidelines document is essential and
that it should be published in the near future to complement this document.</p></sec><sec><title>Development of this Document</title><p>The Standards and Guidelines for Perfusion Practice will serve as a useful guide for
Brazilian cardiac surgical teams to develop institution-specific protocols aimed at
improving the reliability, safety, and effectiveness of cardiopulmonary bypass. We
are aware that the development of a Standards and Guidelines for Perfusion document
alone will not change patient care or outcomes. Safe, reliable, and effective care
will be best served through the implementation of institutional protocols based on
these standards. SBCCV/SBCEC's Standards and Guidelines for Perfusion Practice
reflect the changing landscape for perfusion leading to the safe and optimal
provision of cardiopulmonary bypass for our patients as well as a working team-based
environment that is supportive of these policies.</p><p>We preferred to name this document "Standards and Guidelines for Perfusion Practice"
because this terminology is contemporary and coincides with the language used by
other professional medical societies, including AmSECT <sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>The SBCCV/SBCEC Standards and Guidelines for Perfusion Practice: 2018 is primarily
based on a previous document developed by AmSECT, through its Perfusion Quality
Committee. Initially, AmSECT developed a draft standard for perfusion entitled the
"Essentials for Perfusion Practice, Clinical Function: Conduct of Extracorporeal
Circulation," which was originally endorsed by the membership in 1993<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>, and then reviewed and revised on a
number of occasions<sup>[<xref rid="r10" ref-type="bibr">10</xref>-<xref rid="r12" ref-type="bibr">12</xref>]</sup>. In 2011, the AmSECT Board of
Directors (BOD) asked the International Consortium for Evidence-Based Perfusion
(ICEBP) subcommittee to review and update the "Essentials and Guidelines" document.
The ICEBP conducted a careful review and critique of the document as well as its
relevance and purpose, given the focus on patient safety and surgical outcomes. This
initiative resulted in a revised joint document entitled, the Report from AmSECT's,
International Consortium for Evidence-Based Perfusion American Society of
ExtraCorporeal Technology Standards and Guidelines for Perfusion Practice:
2013<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>. It was developed
as an outgrowth of marrying evidence-based practices from the literature with an
understanding of the context in which care is currently provided. Quite notably at
the same time, the Minimum Standards for Perfusion Practice in Brazil document was
developed as an outgrowth of ongoing collaboration with the International Quality
Improvement Collaborative for Congenital Heart Surgery (IQIC) which is managed from
Boston Children's Hospital and overseen by an international steering committee.
Adoption of the Minimum Standards for Perfusion Practice in Brazil document will
empower perfusionists to effect change at their institution by working towards
practice standards endorsed by their national organizations including minimum safety
devices for all cardiopulmonary bypass cases, monitoring devices to help assess the
adequacy of perfusion, and promotion of a team-based appoach for the care of cardiac
surgical patients. Our vision to improve perfusion practice, and thus patient
outcomes, is for the minimum standards to be adopted as soon as possible by
Brazilian cardiac surgery teams with the comprehensive list of AmSECT standards
phased in as soon as practial given the constraints discussed previously.</p><p>Following translation to Portuguese and critical review by colleagues, this final
document was presented to the SBCCV and SBCEC for their steering commitiee aproval.
A majority of the members of the steering commities of both societies voted to
accept this document as an official position for the Standards and Guidelines for
Perfusion Practice in Brazil. Both documents are included in this manuscript. The
SBCCV and SBCEC endorse this comprehensive report and strongly recommend
implementation.</p></sec><sec><title>Minimum Standards for Perfusion Practice in Brazil:</title><p>Seven standards were identified as the minimum recomendation for perfusion practice.
The SBCCV and SBCEC considers these seven standards as mandatory for all cardiac
surgical centers (Appendix 1).</p></sec><sec><title>SBCCV/SBCEC Comprehensive Standards and Guidelines for Perfusion Practice in
Brazil:</title><p>The Perfusion Standards listed in Appendix 2 have been modified and adapted to the
Brazilian regulatoy agencies' policies and recommendations, by taking The American
Society of ExtraCorporeal Technology (AmSECT) Standards and Guidelines as a
model<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup> and translated to
Portuguese. The final document consists of 15 areas of practice including 50
Standards and 38 Guidelines (Appendix 1) with the first standard focusing on the
development of institutional protocols to support their implementation and use. Each
institution must commit to working towards implementing all standards for patients
undergoing cardiovascular surgery.</p></sec><sec><title>Terminology</title><p>The SBCCV and SBCEC would like to point out that cardiac surgery clinicians must
understand the terminology used in this report. The meanings of these words, as
described in the AmSECT publications, are listed below in order to facilitate
understanding and adoption of the Standards and Guidelines<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>:</p><p><bold>Standards:</bold> practices, technology, and/or conduct of care that
institutions shall meet to fulfill the minimum requirements for cardiopulmonary
bypass</p><p><bold>Guidelines:</bold> recommendation that should be considered and may assist in
the development and implementation of protocols</p><p><bold>Protocols:</bold> an institution-specific written document, derived from
professional standards and guidelines, which contains decision and treatment
algorithms</p><p>In this document, the word <bold>shall</bold> is used to indicate a
<bold>mandatory</bold> requirement</p><p>In this document, the word <bold>should</bold> is used to indicate a
<bold>recommendation</bold></p><p>In this document, the term <bold>surgical care team</bold> is used to indicate the
components of the system: surgeon, anesthesiologist, perfusionist, nurse, and
technicians</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>The SBCCV and SBCEC both recognize the vital need for cultural and clinical changes
in the application of cardiopulmonary bypass in Brazil. Cardiac surgery centers must
adopt the Minimum Standards For Perfusion Practice in Brazil as soon as possible and
work towards adopting the Comprehensive Standards and Guidelines for Perfusion
Practice in Brazil moving forward. Ultimately, a team-based approach utilizing
nationally endorsed standards will help ensure safe and optimal cardiopulmonary
bypass for all our patients and improve outcomes for the complex population we
serve.</p></sec></body><back><ack><title>ACKNOWLEGDEMENTS</title><p>The DECAM/SBCCV and SBCEC would like to thank AmSECT for graciously allowing us to
use their pioneering efforts as we work to improve perfusion practice in Brazil.
Furthermore, the authors would like to thank Robert Baker, Chair of the
International Consortium for Evidence Based Perfusion (ICEBP) Executive Committee
for his review of this document and expert opinion as we developed this
manuscript.</p></ack><fn-group><fn fn-type="other"><p>&#x02022; American Society of ExtraCorporeal Technology [Internet]. American
Society of ExtraCorporeal Technology Standards and Guidelines for Perfusion
Practice 5/23/2017) [Internet]. Chicago (IL): American Society of ExtraCorporeal
Technology; c2019 [cited 2019 Feb 08]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.amsect.org/p/cm/ld/fid=1617">http://www.amsect.org/p/cm/ld/fid=1617</ext-link></p></fn><fn fn-type="other"><p>&#x02022; SBCEC: Sociedade Brasileira de Circula&#x000e7;&#x000e3;o
Extracorp&#x000f3;rea. Normas Brasileiras para o Exerc&#x000ed;cio da
Especialidade de Perfusionista em Circula&#x000e7;&#x000e3;o Extracorp&#x000f3;rea
[Internet]. Campinas (SP): SBCEC; 2017 [cited 2018 Feb 08]. 54 p. Available
from: <ext-link ext-link-type="uri" xlink:href="http://www.sbcec.com.br/br/images/pdf/normas_brasileiras_cec.pdf">http://www.sbcec.com.br/br/images/pdf/normas_brasileiras_cec.pdf</ext-link></p></fn><fn fn-type="other"><p>&#x02022; American Society of Extra-Corporeal Technology. Perfusion practice
survey, September, 1993. Perfusion Life. 1994;11:42-5.</p></fn><fn fn-type="other"><p>&#x02022; American Society of Extra-Corporeal Technology. Guidelines for perfusion
practice. Perfusion Life. 1995;12:20-2.</p></fn><fn fn-type="other"><p>&#x02022; American Society of Extra-Corporeal Technology. Members accept
essential: approve revised code of ethics. Perfusion Life. 1993; 10:14.</p></fn><fn fn-type="other"><p>&#x02022; The Society of Clinical Perfusion Scientists of Great Britain and
Ireland, The College of Clinical Perfusion Scientists of Great Britain and
Ireland. Standards of Practice Document [Internet]. Chicago (IL): American
Society of ExtraCorporeal Technology; c2019 [cited 2019 Feb 08]. Available from:
<ext-link ext-link-type="uri" xlink:href="http://www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40">http://www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40</ext-link></p></fn><fn fn-type="other"><p>&#x02022; The Society of Clinical Perfusion Scientists of Great Britain and
Ireland, The College of Clinical Perfusion Scientists of Great Britain and
Ireland. Code of Practice Document [Internet]. Chicago (IL): American Society of
ExtraCorporeal Technology; c2019 [cited 2019 Feb 08]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=34&#x00026;Itemid=40">http://www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=34&#x00026;Itemid=40</ext-link></p></fn><fn fn-type="other"><p>&#x02022; National Library of Medicine (US), National Institutes of Health (US).
Collection Development Manual: standards and guidelines [Internet]. Bethesda
(MD): National Library of Medicine (US), National Institutes of Health (US);
2004 [cited 2019 Feb 08]. Available from: "<ext-link ext-link-type="uri" xlink:href="http://www.nlm.nih.gov/tsd/acquisitions/cdm/formats46.htmwww.nlm.nih.gov/tsd/acquisitions/cdm/formats46.html">http://www.nlm.nih.gov/tsd/acquisitions/cdm/formats46.htm</ext-link>"<ext-link ext-link-type="uri" xlink:href="http://www.nlm.nih.gov/tsd/acquisitions/cdm/formats46.htmwww.nlm.nih.gov/tsd/acquisitions/cdm/formats46.html">www.nlm.nih.gov/tsd/acquisitions/cdm/formats46.html</ext-link></p></fn><fn fn-type="other"><p>Fast Track</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norwood</surname><given-names>WI</given-names></name></person-group><article-title>Our roots, our future</article-title><source>World J Pediatr Congenit Heart Surg</source><month>4</month><year>2010</year><volume>1</volume><issue>1</issue><fpage>127</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1177/2150135109360814</pub-id><pub-id pub-id-type="pmid">23804733</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norwood Jr</surname><given-names>WI</given-names></name></person-group><article-title>Reply to comment on "our roots, our future"</article-title><source>World J Pediatr Congenit Heart Surg</source><month>10</month><year>2010</year><volume>1</volume><issue>3</issue><fpage>412</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1177/2150135110381793</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gritten</surname><given-names>M</given-names></name></person-group><source>Incident root cause analysis report into the adverse incident that lead
to the death of a pediatric cardiac surgery patient at United Bristol
Healthcare NHS Trust on 27 May 2005</source><comment>[Internet]</comment><year>2007</year><publisher-loc>London</publisher-loc><publisher-name>Society of Clinical Perfusion Scientists of Great Britain &#x00026;
Ireland</publisher-name><date-in-citation content-type="access-date">2019 Feb 08</date-in-citation><size units="pages">53</size><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.scps.org.uk/pdfs/GrittenReport.pdf">http://www.scps.org.uk/pdfs/GrittenReport.pdf</ext-link></comment></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matte</surname><given-names>GS</given-names></name></person-group><article-title>Global outreach to improve the provision of cardiopulmonary
bypass for patients with congenital heart disease</article-title><source>Artif Organs</source><month>1</month><year>2019</year><volume>43</volume><issue>1</issue><fpage>14</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1111/aor.13374</pub-id><pub-id pub-id-type="pmid">30488517</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caneo</surname><given-names>LF</given-names></name><name><surname>Matte</surname><given-names>GS</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>DP</given-names></name><name><surname>Viotto</surname><given-names>G</given-names></name><name><surname>Mazzeto</surname><given-names>M</given-names></name><name><surname>Cestari</surname><given-names>I</given-names></name><etal/></person-group><article-title>Functional Performance of Different Venous Limb Options in
Simulated Neonatal/Pediatric Cardiopulmonary Bypass Circuits</article-title><source>Braz J Cardiovasc Surg</source><comment>[Internet]</comment><month>6</month><year>2018</year><date-in-citation content-type="access-date">2019 Feb 19</date-in-citation><volume>33</volume><issue>3</issue><fpage>224</fpage><lpage>232</lpage><comment>Available from: </comment><pub-id pub-id-type="doi">10.21470/1678-9741-2018-0074</pub-id><pub-id pub-id-type="pmid">30043914</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leirner</surname><given-names>AA</given-names></name><name><surname>Puig</surname><given-names>LB</given-names></name></person-group><article-title>Brazilian pioneers in artificial organs and heart
surgery</article-title><source>Artif Organs</source><month>1</month><year>2012</year><volume>36</volume><issue>1</issue><fpage>11</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1111/j.1525-1594.2011.01426.x</pub-id><pub-id pub-id-type="pmid">22250820</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>SBCEC: Sociedade Brasileira de Circula&#x000e7;&#x000e3;o
Extracorp&#x000f3;rea</collab></person-group><source>Normas Brasileiras para o Exerc&#x000ed;cio da Especialidade de
Perfusionista em Circula&#x000e7;&#x000e3;o Extracorp&#x000f3;rea</source><comment>[Internet]</comment><year>2017</year><publisher-loc>Campinas(SP)</publisher-loc><publisher-name>SBCEC</publisher-name><date-in-citation content-type="access-date">2018 Feb 08</date-in-citation><size units="pages">54</size><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.sbcec.com.br/br/images/pdf/normas_brasileiras_cec.pdf">http://www.sbcec.com.br/br/images/pdf/normas_brasileiras_cec.pdf</ext-link></comment></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>American Society of ExtraCorporeal Technology</collab></person-group><source>Standards and Guidelines for Perfusion Practice</source><comment>[Internet]</comment><publisher-loc>Chicago (IL)</publisher-loc><publisher-name>American Society of ExtraCorporeal Technology</publisher-name><year>2017</year><date-in-citation content-type="access-date">2019 Feb 08</date-in-citation><size units="pages">52</size><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.theaacp.com/wp-content/uploads/2017/11/AmSECT_Perfusion_SG_legal_ICEBP_final_2017.pdf">http://www.theaacp.com/wp-content/uploads/2017/11/AmSECT_Perfusion_SG_legal_ICEBP_final_2017.pdf</ext-link></comment></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Society of Extra-Corporeal Technology</collab></person-group><article-title>Members accept essentials; approve revised code of
ethics</article-title><source>Perfusion Life</source><year>1993</year><volume>10</volume><fpage>14</fpage><lpage>14</lpage></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurusz</surname><given-names>M</given-names></name></person-group><article-title>Standards of practice in perfusion</article-title><source>Perfusion</source><month>5</month><year>1994</year><volume>9</volume><issue>3</issue><fpage>211</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">7949575</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>AG</given-names></name><name><surname>Kurusz</surname><given-names>M</given-names></name></person-group><article-title>Perfusion standards and guidelines</article-title><source>Perfusion</source><month>7</month><year>1997</year><volume>12</volume><issue>4</issue><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">9234398</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurusz</surname><given-names>M</given-names></name></person-group><article-title>Standards update on perfusion equipment and
practice</article-title><source>Perfusion</source><month>7</month><year>2005</year><volume>20</volume><issue>4</issue><fpage>205</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">16130366</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>RA</given-names></name><name><surname>Bronson</surname><given-names>SL</given-names></name><name><surname>Dickinson</surname><given-names>TA</given-names></name><name><surname>Fitzgerald</surname><given-names>DC</given-names></name><name><surname>Likosky</surname><given-names>DS</given-names></name><name><surname>Mellas</surname><given-names>NB</given-names></name><etal/></person-group><article-title>Consortium for Evidence-Based Perfusion: American Society of
Extracorporeal Technology Standards and Guidelines for Perfusion Practice:
2013</article-title><source>J Extra Corpor Technol</source><month>9</month><year>2013</year><volume>45</volume><issue>3</issue><fpage>156</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">24303597</pub-id></element-citation></ref></ref-list><app-group><app id="app1"><title>Appendix 1</title><p><bold>Minimum Standards for Perfusion Practice in Brazil</bold></p><p><bold>Minimum Standard 1:</bold> Perfusion practice must be guided by a written
set of policies developed within the institution and approved by physician
leadership. (See also Comprehensive Standard 1).</p><p><bold>Minimum Standard 2:</bold> Each perfusionist must be adequately trained
through a defined education process. Staff must participate in annual continuing
education activities and institutional based quality improvement programs. (See
also Comprehensive Standards 2 and 13).</p><p><bold>Minimum Standard 3:</bold> The care team must discuss the bypass plan
before incision; anticoagulation plan and target ACT values, pump flows,
hematocrit management, target temperature, myocardial protection plan, blood gas
management, blood pressure goals, etc. Closed-loop communication must be used
during the procedure. The care team must have real-time multidisciplinary
discussion regarding all concerns during bypass (<italic>i.e.</italic>, blood
pressure too low, poor venous drainage, falling NIRS, need for blood product
transfusion, etc.). (See also Comprehensive Standards 1, 3, 5, 8 and 12).</p><p><bold>Minimum Standard 4:</bold> Perfusion equipment must be maintained by
qualified personnel. An appropriately sized selection of equipment and
standardized disposables must be used for each patient with back-up equipment
available. Back-up supplies of cannulae and connectors, etc., must be located
next to the primary perfusionist in the OR. The bypass circuit must be set-up on
the heart-lung machine before the patient arrives in the operating room. (See
also Comprehensive Standards 6 and 14).</p><p><bold>Minimum Standard 5:</bold> The perfusion record must include sufficient
timed data to reconstruct a bypass run, include the prebypass checklist and list
the products used for the case. The perfusion record must be part of part of the
patient's medical record. (See also Comprehensive Standards 3,4, 5, 7, 8, 9 and
12).</p><p><bold>Minimum Standard 6:</bold> The follow monitoring and safety devices must be
used for all patients; patient and circuit temperature probes, reservoir level
sensor, bypass system and cardioplegia temperature and pressure, an arterial
line filter, flow probe, one-way valve on the vent line, back-up oxygen supply,
SvO2 monitoring and a hand crank. The following items should be considered for
every case: NIRS monitoring and bubble detection. Servoregulation must be
utilized where available. Blood gases must be verified on a defined schedule.
(See also Comprehensive Standards 6, 7, 10 and 11).</p><p><bold>Minimum Standard 7:</bold> The perfusion team must have adequate storage
space near the operating theater for back-up and emergency supplies. A
comfortable chair which allows for close monitoring of the perfusion circuit
should be available to the perfusoinist during bypass. (See also Comprehensive
Standard 14).</p></app><app id="app2"><title>Appendix 1</title><p><bold>Padr&#x000f5;es M&#x000ed;nimos para a Pr&#x000e1;tica de Perfus&#x000e3;o no
Brasil</bold></p><p><bold>Minimum Standard 1:</bold> As pr&#x000e1;ticas de perfus&#x000e3;o devem ser
orientadas por um conjunto de pol&#x000ed;ticas desenvolvidas dentro da
institui&#x000e7;&#x000e3;o, dispon&#x000ed;veis na forma escrita e aprovadas
pelo)a) chefe da equipe cir&#x000fa;rgica (para mais detalhes, veja Comprehensive
Standard 1).</p><p><bold>Minimum Standard 2:</bold> Cada perfusionista deve ser treinado
adequadamente em um processo de forma&#x000e7;&#x000e3;o definido. Toda a equipe
de perfusionistas deve participar das atividades anuais de
educa&#x000e7;&#x000e3;o continuada e dos programas de melhoria de qualidade da
institui&#x000e7;&#x000e3;o (para mais detalhes, veja Comprehensive Standards 2 e
13).</p><p><bold>Minimum Standard 3:</bold> A equipe cir&#x000fa;rgica deve discutir o plano
de perfus&#x000e3;o antes da incis&#x000e3;o na pele, assim como
anticoagula&#x000e7;&#x000e3;o e valores de TCA alvo, fluxos de perfus&#x000e3;o,
hemat&#x000f3;crito alvo e pol&#x000ed;tica transfusional, temperatura alvo,
estrat&#x000e9;gia de prote&#x000e7;&#x000e3;o mioc&#x000e1;rdica e manuseio da
press&#x000e3;o arterial. A comunica&#x000e7;&#x000e3;o em al&#x000e7;a fechada
(<italic>closed loop</italic>) deve ser usada durante todo o procedimento. A
equipe deve promover uma discuss&#x000e3;o multidisciplinar em tempo real sobre
todas as preocupa&#x000e7;&#x000f5;es durante a circula&#x000e7;&#x000e3;o
extracorp&#x000f3;rea (ou seja, press&#x000e3;o arterial muito baixa, dificuldade
com a drenagem venosa, queda dos valores da oximetria cerebral n&#x000e3;o
invasiva - near-infrared spectroscopy - NIRS, necessidade de hemoderivados,
dentre outras) (para mais detalhes, veja Comprehensive Standards 1, 3, 5, 8 e
12).</p><p><bold>Minimum Standard 4:</bold> A manuten&#x000e7;&#x000e3;o do equipamento de
perfus&#x000e3;o deve ser realizada por pessoal qualificado. A escolha adequada
dos equipamentos necess&#x000e1;rios e dos descart&#x000e1;veis padronizados em
protocolo institucional deve ser realizada para cada paciente, assim como um
equipamento de reserva deve estar dispon&#x000ed;vel para a perfus&#x000e3;o. Os
suprimentos e componentes descart&#x000e1;veis do circuito (c&#x000e2;nulas e
conectores etc.) em duplicidade devem estar localizados o mais pr&#x000f3;ximo
poss&#x000ed;vel do perfusionista respons&#x000e1;vel pelo caso, preferencialmente
na sala de cirurgia. O circuito de circula&#x000e7;&#x000e3;o extracorp&#x000f3;rea
(CEC) deve ser montado na m&#x000e1;quina de CEC antes que o paciente chegue
&#x000e0; sala de opera&#x000e7;&#x000e3;o (para mais detalhes, veja Comprehensive
Standards 6 e 14).</p><p><bold>Minimum Standard 5:</bold> A ficha (registro) de perfus&#x000e3;o deve
incluir dados suficientes para reconstruir a perfus&#x000e3;o por inteiro,
incluindo um checklist pr&#x000e9;-CEC e contendo todas as drogas e
descart&#x000e1;veis utilizados para a condu&#x000e7;&#x000e3;o do caso. A ficha de
perfus&#x000e3;o deve ser parte do prontu&#x000e1;rio m&#x000e9;dico do paciente e
deve ser anexada a ele. Uma c&#x000f3;pia deve ser mantida com a equipe de
perfus&#x000e3;o (para mais detalhes, veja Comprehensive Standards 3, 4, 5, 7, 8,
9 e 12).</p><p><bold>Minimum Standard 6:</bold> Os seguintes dispositivos de
monitora&#x000e7;&#x000e3;o e seguran&#x000e7;a devem ser utilizados para todos os
pacientes: sensores de temperatura no paciente, no circuito venoso e arterial e
na cardioplegia; sensor de n&#x000ed;vel de reservat&#x000f3;rio; sensor de
bolhas; sistema de press&#x000e3;o na linha arterial e na linha de infus&#x000e3;o
da cardioplegia; filtro de linha arterial; flux&#x000f4;metro na linha arterial;
v&#x000e1;lvula unidirecional na linha aspira&#x000e7;&#x000e3;o da
aorta/&#x000e1;trio esquerdo; cilindro de oxig&#x000ea;nio de reserva; equipamento
de monitora&#x000e7;&#x000e3;o da SvO2; monitor de oximetria cerebral
cont&#x000ed;nua (NIRS); detector de bolhas e "<italic>hand cranck</italic>" para
manuseio manual da bomba arterial. A servorregula&#x000e7;&#x000e3;o deve ser
utilizada sempre que dispon&#x000ed;vel. Os gases no sangue devem ser verificados
em uma rotina predefinida em protocolo (para mais detalhes, veja Comprehensive
Standards 6, 7, 10 e 11).</p><p><bold>Minimum Standard 7:</bold> A equipe de perfus&#x000e3;o deve ter
espa&#x000e7;o de armazenamento adequado perto da sala de cirurgia para
suprimentos de emerg&#x000ea;ncia. Uma cadeira confort&#x000e1;vel que permita um
monitoramento pr&#x000f3;ximo do circuito de perfus&#x000e3;o deve estar
dispon&#x000ed;vel durante a perfus&#x000e3;o (para mais detalhes, veja
Comprehensive Standard 14).</p></app><app id="app3"><title>Appendix 2</title><p><bold>SBCCV/SBCEC Comprehensive Standards and Guidelines for Perfusion Practice
in Brazil*</bold></p><p><bold>Standard 1: Development of Institutionally based Protocols</bold></p><p><bold>Standard 1.1:</bold> As a mechanism for applying each standard to clinical
practice, an institution or service provider shall develop and implement an
operating procedure (protocol) for each of the standards.</p><p><bold>Standard 1.2:</bold> The protocol shall be:</p><p>
<list list-type="bullet"><list-item><p>Approved by the Chairman of Cardiac Surgery, or his or her designee,
Director of Perfusion or equivalent, and other relevant clinical
governance committees if available.</p></list-item><list-item><p>Reviewed and revised annually or more frequently when deemed
necessary.</p></list-item></list>
</p><p><bold>Guideline 1.1:</bold> Deviation from protocol may be at the discretion of
the Surgical Care Team and should be documented in the perfusion record.</p><p><bold>Standard 2: Qualification, Competency, and Support Staff</bold></p><p><bold>Standard 2.1:</bold> Extracorporeal circulation should only be performed by
a professional trained among the professions recognized by SBCEC and SBCCV as
competent to carry out the procedure; have a post-graduate degree recognized by
the Brazilian Ministry of Education (MEC) with minimum workload described in
article 12 of the Brazilian Standards for the Exercise of the Specialty of
Perfusionist in Extracorporeal Circulation or SBCEC Specialist
Degree<sup>[1]</sup>, validated by this society; or professionals who fall
within the sole paragraph of Article 2 of the aforementioned Standard.</p><p><bold>Standard 2.2:</bold> Perfusionist competency shall be assessed annually to
evaluate compliance with departmental protocols.</p><p><bold>Standard 2.3:</bold> The perfusionist shall attend, participate, and engage
in perfusion-related continuing education courses on an annual basis.</p><p><bold>Standard 2.4:</bold> Support staff shall be available on-site to assist the
primary perfusionist during CPB procedures.</p><p><bold>Guideline 2.1:</bold> An individual graduating from an accredited perfusion
education program should complete all requirements for the Sociedade Brasileira
de Circula&#x000e7;&#x000e3;o Extracorp&#x000f3;rea (SBCEC) certification.</p><p><bold>Guideline 2.2:</bold> A standardized process should be developed and
followed to identify, orient, and educate support staff to ensure they have
general knowledge of the duties performed by the perfusionist, flow of the
operation, and location of primary and ancillary items required during CPB.
Support staff may include a perfusionist, nursing, technical, or nontechnical
staff.</p><p><bold>Guideline 2.3:</bold> A standardized process to educate, train, and to
evaluate annually perfusion staff should be developed and followed.</p><p><bold>Guideline 2.4:</bold> It is recommended any perfusion procedure be
conducted by two perfusionists, ensuring a better procedural safety.</p><p><bold>Guideline 2.5:</bold> Use of Personal Protective Equipment: The
perfusionist should use Personal Protective Equipment (PPE), such as masks,
goggles and procedure gloves while conducting CPB. Gloves should be changed
after drawing a blood sample, blood products administrtion and manipulation
(blood bag) or whenever exposed to a blood splash<sup>[3]</sup>.</p><p><bold>Standard 3: Perfusion Record</bold></p><p><bold>Standard 3.1:</bold> The perfusion record (written and/or electronic) for
each CPB procedure shall be included as part of the patient's permanent medical
record. The perfusion record shall be maintained and stored according to
institution policy for retaining patient medical records.</p><p><bold>Standard 3.2:</bold> The record shall include:</p><p>
<list list-type="bullet"><list-item><p>Patient information including demographics and preoperative risk
factors (Appendix A)</p></list-item><list-item><p>Information sufficient to accurately describe the procedure,
personnel, and equipment (Appendix B).</p></list-item><list-item><p>Patient physiological parameters documented at a frequency determined
by institutional protocol (Appendix C).</p></list-item><list-item><p>Blood gas and anticoagulation monitoring results (Appendix D).</p></list-item><list-item><p>Signature of the perfusionist (and all relief perfusionists)
performing the procedure.</p></list-item></list>
</p><p><bold>Guideline 3.1:</bold> There should be perfusion (writing and/or electronic)
record for each performed CPB procedure. The perfusion record must include a
free text space for recording comments, including verbal orders given by the
medical staff, including verbal orders given by the supervising physician.</p><p><bold>Guideline 3.2:</bold> The perfusion record should include the signatures of
the physician(s) providing oversight for the CPB procedure.</p><p><bold>Guideline 3.3:</bold> Raw data (<italic>e.g</italic>., blood flow,
pressure, and temperature values) contained in electronic perfusion databases
should be stored for a time period in accordance with your institution's policy
for retaining electronic patient medical records.</p><p><bold>Standard 4: Checklist</bold></p><p><bold>Standard 4.1:</bold> The perfusionist shall use a checklist for each CPB
procedure<sup>[4]</sup>.</p><p><bold>Standard 4.2:</bold> Checklists shall be included as part of the patient's
permanent medical record.</p><p><bold>Guideline 4.1:</bold> The perfusionist should use checklists in a
read-verify manner where critical steps that should have been performed are
confirmed<sup>[4]</sup>. Completion of the check-list should be performed by
two people, one person being the primary perfusionist responsible for operation
of the heart lung machine during the intraoperative period. In services where
there is no availability of another professional perfusionist, a systematic
routine of checking the items contained in the checklist should be adopted, in
order to minimize the occurrence of adverse events.</p><p><bold>Guideline 4.2:</bold> The perfusionist should use a checklist throughout
the entire perioperative period (<italic>e.g.</italic>, setup, pre-bypass,
initial onset of bypass, before cessation of bypass, postbypass, and/or any
return to bypass).</p><p><bold>Guideline 4.3:</bold> The perfusionist should use a checklist for other
ancillary perfusion services (<italic>e.g.</italic>, cell salvage, intra-aortic
balloon pump, extracorporeal membrane oxygenation).</p><p><bold>Standard 5: Communication</bold></p><p><bold>Standard 5.1:</bold> A patient-specific management plan for the CPB
procedure shall be prepared and communicated to the surgical team either during
the preoperative briefing or before beginning the procedure<sup>[5]</sup>.</p><p><bold>Guideline 5.1:</bold> The use of cellular telephone technology in the
operating room should be avoided, since it is a distracting factor and
predispose the patient to the risk of contamination by potentially infectious
bacteria, compromising the quality and safety of the health assistance. When
their use is unavoidable, the devices must be pre-sanitized according to the
institution protocol for infection control<sup>[6-8]</sup>.</p><p><bold>Guideline 5.2:</bold> Protocol-driven communication (<italic>e.g</italic>.,
closed-loop) should be used to acknowledge verbal commands, verify the content,
and reduce ambiguity<sup>[9-11]</sup>.</p><p><bold>Guideline 5.3:</bold> The primary perfusionist should participate in the
postprocedure debrief with the surgical team.</p><p><bold>Standard 6: Safety Devices</bold></p><p><bold>Standard 6.1:</bold> Pressure monitoring of the arterial line, cardioplegia
delivery systems, and venous reservoir (when vacuum assisted venous drainage is
used) shall be used during CPB procedures.</p><p>
<list list-type="bullet"><list-item><p>The pressure monitor shall be either servoregulated to control the
arterial/cardioplegia pump or to allow interruption to the
arterial/cardioplegia flow.</p></list-item><list-item><p>The pressure monitor shall include an audible and visual alarm.</p></list-item></list>
</p><p><bold>Standard 6.2:</bold> A bubble detector shall be used during CPB
procedures.</p><p>
<list list-type="bullet"><list-item><p>The gross/macrobubble detector shall be used to control the arterial
pump or to allow interruption of the arterial blood flow.</p></list-item><list-item><p>The detector system shall include an audible and visual alarm and be
positioned according to manufacturer instructions for use to enable
timely identification and action.</p></list-item></list>
</p><p><bold>Standard 6.3:</bold> A level sensor shall be used during CPB procedures
using a (hard-shell) reservoir.</p><p>
<list list-type="bullet"><list-item><p>The level sensor shall be either servo-regulated to control the
arterial pump or to allow interruption of the arterial blood
flow.</p></list-item><list-item><p>The level sensor shall include an audible and visual alarm and be
positioned according to the manufacturer's instructions to allow an
appropriate reaction time and a safe operational volume.</p></list-item></list>
</p><p><bold>Standard 6.4:</bold> Temperature monitoring of the arterial outflow from
the oxygenator shall be used during CPB procedures.</p><p>
<list list-type="bullet"><list-item><p>The temperature sensor shall include an audible and visual alarm to
prevent high arterial outlet temperatures.</p></list-item></list>
</p><p><bold>Standard 6.5:</bold> An arterial-line filter shall be used during CPB
procedures.</p><p><bold>Standard 6.6:</bold> A one-way valve in the vent line shall be used during
CPB procedures.</p><p><bold>Standard 6.7:</bold> A method for retrograde flow avoid- ance when using a
centrifugal pump shall be used during CPB procedures.</p><p>
<list list-type="bullet"><list-item><p>At least one method to prevent retrograde flow shall be used for
systems using centrifugal pumps for systemic circulation. Examples
of retrograde avoidance systems may include the following:</p></list-item><list-item><p>One-way flow valves;</p></list-item><list-item><p>Hard-stop detent controls to prevent accidental reduction in pump
speed;</p></list-item><list-item><p>Electronically activated arterial line clamps; or</p></list-item><list-item><p>A low-speed visual and audible alarm.</p></list-item></list>
</p><p><bold>Standard 6.8:</bold> An anesthetic gas scavenge line shall be used whenever
inhalation agents are introduced into the circuit during CPB procedures.</p><p><bold>Standard 6.9:</bold> Hand cranks shall be readily available during CPB
procedures.</p><p><bold>Standard 6.10:</bold> A back-up gas supply shall be available during CPB
procedures.</p><p><bold>Standard 6.11:</bold> A back-up battery supply for the CPB machine shall be
available during CPB procedures.</p><p><bold>Guideline 6.1:</bold> A ventilating gas oxygen analyzer should be used
during CPB procedures.</p><p><bold>Guideline 6.2:</bold> A level sensor should be used during CPB procedures
using a soft-shell reservoir.</p><p>
<list list-type="bullet"><list-item><p>The level sensor should be either servo-regulated to control the
arterial pump or to allow interruption of the arterial blood
flow.</p></list-item><list-item><p>The level sensor should include an audible and visual alarm and be
positioned according to manufacturer's instructions to allow an
appropriate reaction time and a safe operational volume.</p></list-item><list-item><p>The use of an air bubble detector distal to the outlet can be used as
a surrogate level detector.</p></list-item></list>
</p><p><bold>Guideline 6.3:</bold> The tubing pack should be provided by the
manufacturer "pre-assembled", pre-connected and in a sterile tray separating the
circuit that will be used in the surgical field of the one that will be mounted
in the heart-lung machine (HLM), offering more safety to the perfusion itsef and
granting faster circuit assembly.</p><p><bold>Standard 7: Monitoring (obs: to be performed in conjunction with Standard
3)</bold></p><p><bold>Standard 7.1:</bold> Patient arterial blood pressure shall be monitored
continually during CPB.</p><p><bold>Standard 7.2:</bold> Arterial line pressure shall be monitored continually
during CPB.</p><p><bold>Standard 7.3:</bold> Arterial blood flow shall be monitored continually
during CPB.</p><p><bold>Standard 7.4:</bold> Cardioplegia dose, delivery method, line pressure
(antegrade), coronary sinus pressure (retrograde), and ischemic intervals shall
be monitored continually during CPB.</p><p><bold>Standard 7.5:</bold> Patient and device temperatures shall be monitored
continually during CPB.</p><p>
<list list-type="bullet"><list-item><p>Patient (<italic>e.g</italic>., nasopharyngeal, rectal, bladder,
esophageal).</p></list-item><list-item><p>Heart-lung machine (arterial, venous and cardioplegia).</p></list-item><list-item><p>Heater cooler (H<sub>2</sub>O temperature).</p></list-item></list>
</p><p><bold>Standard 7.6:</bold> Blood gas analyses shall be monitored con- tinually or
at regular intervals during CPB (Appendix D).</p><p><bold>Standard 7.7:</bold> Hematocrit (or hemoglobin) shall be monitored
continually during CPB.</p><p><bold>Standard 7.8:</bold> Oxygen fraction and gas flow rates shall be monitored
continually during CPB (Appendix D).</p><p><bold>Standard 7.9:</bold> The percentage of venous line occlusion of the venous
occluder shall be monitored continually during CPB.</p><p><bold>Standard 7.10:</bold> Venous oxygen saturation shall be monitored
continually during CPB.</p><p><bold>Guideline 7.1:</bold> Carbon dioxide removal should be monitored
continually during CPB.</p><p><bold>Guideline 7.2:</bold> Arterial oxygen saturation should be monitored
continually during CPB.</p><p><bold>Guideline 7.3:</bold> The following patient pressures should be monitored
during CPB:</p><p>
<list list-type="bullet"><list-item><p>Central venous pressure; and/or</p></list-item><list-item><p>Pulmonary artery blood pressure.</p></list-item></list>
</p><p><bold>Guideline 7.4:</bold> Continuous in-line blood gas monitoring should be
used during CPB.</p><p><bold>Guideline 7.5:</bold> Cerebral oximetry should be used during CPB.</p><p><bold>Guideline 7.6:</bold> Arterial blood flow should be monitored continually
at a point in the CPB circuit where it accurately reflects the flow delivered to
the patient during CPB (<italic>e.g.</italic>, distal to intracircuit
shunts).</p><p><bold>Standard 8: Anticoagulation</bold></p><p><bold>Standard 8.1:</bold> The perfusionist, in collaboration with the
physician-in-charge, shall define the intended treatment algorithm for
anticoagulation management (heparin) and an alternative algorithm for when
heparin is not suitable, including acceptable ranges for activated clotting time
(ACT).</p><p><bold>Standard 8.2:</bold> The perfusionist shall work closely with the surgical
care team to monitor and treat the patient's anti- coagulation status before,
during, and after the CPB period.</p><p><bold>Guideline 8.1:</bold> The surgical care team should determine the target
ACT by considering relevant factors, including variability in the measurement of
ACT attributed to the device's performance characteristics.</p><p><bold>Guideline 8.2:</bold> Patient-specific initial heparin dose should be
determined by one of the following methods:</p><p>
<list list-type="bullet"><list-item><p>Weight;</p></list-item><list-item><p>Dose-response curve (automated or manual);</p></list-item><list-item><p>Blood volume; or</p></list-item><list-item><p>Body surface area.</p></list-item></list>
</p><p><bold>Guideline 8.3:</bold> Anticoagulation monitoring should include the testing
of ACT. Additional monitoring tests may include:</p><p>
<list list-type="bullet"><list-item><p>Heparin level measurement, <italic>e.g.</italic>, heparin/protamine
titration or unfractionated heparin level;</p></list-item><list-item><p>Partial thromboplastin time;</p></list-item><list-item><p>Thromboelastograph;</p></list-item><list-item><p>Thrombin time; and/or</p></list-item><list-item><p>Anti-Xa.</p></list-item></list>
</p><p>Any point-of-care (POC) device should be used under the hospital clinical
laboratory policies. The Clinical Laboratory Director is responsible for all
POCs tests performed within the institution. The clinical laboratory should
provide documented standard procedures to all sites using POC devices for
guidance on its pre-analytical, analytical and post-analytical phases,
including:</p><p>
<list list-type="alpha-lower"><list-item><p>systematic recording and release of interim results;</p></list-item><list-item><p>procedure for potentially critical lab test results;</p></list-item><list-item><p>systematic review of results and release of reports by qualified
professional.</p></list-item></list>
</p><p>The clinical laboratory should keep records for the quality control program as
well as the standards procedures to perform them. The clinical laboratory should
promote and maintain records of its ongoing users' education process for POC
equipments<sup>[12]</sup>.</p><p><bold>Guideline 8.4:</bold> Additional doses of heparin during CPB should be
determined by using an ACT and/or heparin/ protamine titration. Note: in
patients requiring longer CPB times (&#x0003e;2 to 3 hours), maintenance of higher
and/or patient-specific heparin concentrations during CPB may be considered to
reduce hemostatic system activation, reduce consumption of platelets and
coagulation proteins, and to reduce blood transfusion (Class IIb, Level of
evidence B)<sup>[13]</sup>.</p><p><bold>Guideline 8.5:</bold> Heparin reversal should be confirmed by ACT and/or
heparin/protamine titration.</p><p><bold>Standard 9: Blood Management</bold></p><p><bold>Standard 9.1:</bold> The perfusionist shall participate in efforts to
minimize hemodilution and avoid unnecessary blood
transfusions<sup>[13]</sup>.</p><p><bold>Standard 9.2:</bold> The perfusionist shall minimize the CPB circuit size
to reduce prime volume<sup>[13]</sup>.</p><p><bold>Standard 9.3:</bold> The perfusionist shall calculate and communicate to
the surgical team before initiating CPB a patient's predicted postdilutional
hemoglobin or hematocrit.</p><p><bold>Guideline 9.1:</bold> Blood management efforts should include the
following<sup>[13]</sup>:</p><p>
<list list-type="bullet"><list-item><p>Participate in preoperative briefings (discussions) with the surgical
care team (Standard 5.1) regarding transfusion strategies and target
hematocrit values.</p></list-item><list-item><p>Participation in a multidisciplinary blood management team.</p></list-item><list-item><p>Minimize hemodilution by:</p></list-item><list-item><p>Matching the size of the CPB circuit to the size of the patient;</p></list-item><list-item><p>Autologous priming of CPB circuit, including retrograde arterial and
venous antegrade priming;</p></list-item><list-item><p>Biocompatible coating on the surface of all CPB components;</p></list-item><list-item><p>Perioperative blood cell recovery and reinfusion after being
appropriately processed; and CPB circuit blood salvage at the end of
the procedure.</p></list-item></list>
</p><p><bold>Guideline 9.2:</bold> Point-of-care hemostasis monitoring should be used to
minimize blood loss.</p><p>Monitoring may include:</p><p>
<list list-type="bullet"><list-item><p>International normalized ratio;</p></list-item><list-item><p>Partial thromboplastin time;</p></list-item><list-item><p>Prothrombin time;</p></list-item><list-item><p>Thrombin time;</p></list-item><list-item><p>Thromboelastography/thromboelastometry;</p></list-item><list-item><p>Platelet count; and/or</p></list-item><list-item><p>Platelet function analysis.</p></list-item></list>
</p><p><bold>Standard 10: Gas Exchange</bold></p><p><bold>Standard 10.1:</bold> Gas exchange shall be maintained during CPB according
to protocol accounting for:</p><p>
<list list-type="bullet"><list-item><p>The individual patient characteristics/risk profile;</p></list-item><list-item><p>Oxygenator type, design, and instructions for use; and</p></list-item><list-item><p>Blood flow, temperature, and metabolic demand.</p></list-item></list>
</p><p><bold>Standard 10.2:</bold> Devices used to measure gas exchange shall be
calibrated according to the manufacturer's instructions for use.</p><p><bold>Standard 10.3:</bold> Blood gas analysis shall be performed and recorded
according to protocol.</p><p><bold>Guideline 10.1:</bold> Point-of-care testing should be considered to
provide accurate and timely information for blood gas
analysis<sup>[14]</sup>.</p><p><bold>Guideline 10.2:</bold> Oxygen delivery and consumption calculations should
be used to evaluate and optimize gas exchange<sup>[15]</sup>:</p><p>Oxygen delivery: DO<sub>2</sub> = 10 CI CaO<sub>2</sub></p><p>Oxygen consumption: VO<sub>2</sub> = 10 CI (CaO<sub>2</sub> -
CvO<sub>2</sub>)</p><p>Where:</p><p>CaO<sub>2</sub> (arterial oxygen content) = (Hb x 1.36 x SaO<sub>2</sub>) +
(0.0031 x PaO<sub>2</sub>)</p><p>and</p><p>CvO2 (mixed venous oxygen content) = (Hb x 1.36 x SvO<sub>2</sub>) + (0.0031 x
PvO<sub>2</sub>)</p><p>CI = cardiac index</p><p>HB = hemoglobin</p><p>PaO<sub>2</sub> = partial pressure of oxygen in arterial blood</p><p>PvO<sub>2</sub> = partial pressure of oxygen in venous blood</p><p>SaO<sub>2</sub> = arterial oxygen saturation</p><p>SvO<sub>2</sub> = venous oxygen saturation</p><p><bold>Guideline 11.1:</bold> Variance from intended and targeted blood flow
should be communicated to the physician-in-charge.</p><p><bold>Guideline 11.2:</bold> Appropriate blood flow rate should be determined by
evaluation of:</p><p>
<list list-type="bullet"><list-item><p>Acid base balance</p></list-item><list-item><p>Base excess;</p></list-item><list-item><p>Anesthetic level;</p></list-item><list-item><p>Arterial blood pressure;</p></list-item><list-item><p>Cerebral oximetry;</p></list-item><list-item><p>Lactate burden; and</p></list-item><list-item><p>Oxygen delivery and consumption (refer to Guideline 10.2 for
formulae).</p></list-item><list-item><p>Venous pO<sub>2</sub></p></list-item><list-item><p>Arterial pO<sub>2</sub></p></list-item><list-item><p>Hemoglobin concentration</p></list-item><list-item><p>Arterial oxygen saturation</p></list-item><list-item><p>Systemic vascular resistance (SVR);</p></list-item><list-item><p>Temperature; and</p></list-item><list-item><p>Venous oxygen saturation.</p></list-item></list>
</p><p><bold>Standard 12: Blood Pressure</bold></p><p><bold>Standard 12.1:</bold> The perfusionist, in collaboration with the
physician-in-charge, shall define and communicate the intended treatment
algorithm for blood pressure management before CPB, including acceptable ranges
for blood pressure. Obs: in many circumstances, the physician-in-charge may
direct the perfusionist to modify the intended blood pressure management to
address circumstances occurring during the CPB procedure.</p><p><bold>Standard 12.2:</bold> The perfusionist shall work closely with the surgical
care team to maintain blood pressure according to protocol during CPB.</p><p><bold>Guideline 12.1:</bold> Variance from intended and targeted blood pressure
should be documented and communicated to the physician-in-charge to allow for
changes in the blood pressure management plan.</p><p><bold>Standard 13: Quality Assurance and Improvement</bold></p><p><bold>Standard 13.1:</bold> The perfusionist shall actively participate in both
institutional and departmental quality assurance and improvement programs.</p><p><bold>Guideline 13.1:</bold> The perfusionist should collect data regarding
conduction of the perfusion through a clinical registry or database.</p><p><bold>Guideline 13.2:</bold> The perfusionist should use this data for quality
control and improvement projects<sup>[16,17]</sup>.</p><p><bold>Guideline13.3:</bold> The perfusionist should evaluate the postoperative
period of the patient in a standard form (Appendix E), storing data for periodic
evaluation of perfusion in his service<sup>[18]</sup>.</p><p><bold>Guideline 13.4:</bold> Specific and periodic meetings should be held in his
service for the review of avoidable errors occurring in his daily practice.</p><p><bold>Guideline 13.5:</bold> Any adverse events shall be notified in writing to
the responsible sector, which shall forward them to the regulatory agencies and
other competent areas after their verification. The service should encourage
notifications to be always carried out, establishing a direct line of
communication between the team and the risk management department, guaranteeing
their confidentiality<sup>[19]</sup>.</p><p><bold>Standard 14: Maintenance</bold></p><p><bold>Standard 14.1:</bold> The perfusionist shall assure that properly
maintained and functioning equipment is used in the conduct of CPB, including
(but not limited to):</p><p>
<list list-type="bullet"><list-item><p>Heart-lung machine Pumps</p></list-item><list-item><p>Timers</p></list-item><list-item><p>Pressure monitors</p></list-item><list-item><p>Temperature monitors</p></list-item><list-item><p>Low-level alarm</p></list-item><list-item><p>Air bubble detector(s)</p></list-item><list-item><p>Blood flow sensors</p></list-item><list-item><p>Heater/cooler</p></list-item><list-item><p>Anesthetic vaporizer</p></list-item><list-item><p>Oxygen blender/flow meter</p></list-item><list-item><p>Oxygen analyzer</p></list-item><list-item><p>Ancillary equipment</p></list-item><list-item><p>Intra-arterial blood pressure</p></list-item><list-item><p>Vascular assist device</p></list-item><list-item><p>Cell salvage device</p></list-item></list>
</p><p><bold>Standard 14.2:</bold> Preventive maintenance on perfusion equipment shall
be performed and documented on a regularly scheduled basis by the perfusion team
and/or appropriately trained and qualified biomedical engineering staff. Any or
all of the following may determine the interval of such maintenance:</p><p>
<list list-type="bullet"><list-item><p>Manufacturer recommendations;</p></list-item><list-item><p>External accrediting agency guidelines; and/or</p></list-item><list-item><p>Institutional requirements.</p></list-item></list>
</p><p><bold>Note:</bold> In the case of consigned equipment, the owner of the CPB
machine is responsible for maintaining the perfusion set, and all liabilities
and legal issues will be assigned to it. In the case of an adverse event
resulting from the use of this equipment, even if the equipment is proven to be
defective, even with adequate maintenance and not related to improper use by the
perfusionist, the owner of the equipment and not the institution shall be held
liable.</p><p>Therefore, there should be an updated document for each of the equipment used,
with dates and details of preventive and corrective maintenance and that should
be filed in the perfusion service/department or clinical engineering unit of the
institution<sup>[20]</sup>.</p><p><bold>Standard 14.3:</bold> The organization shall have a written procedure for
perfusion equipment failures<sup>[21]</sup>.</p><p><bold>Standard 14.4:</bold> Appropriate back-up perfusion supplies shall be
readily available. Obs: when CPB machine is not property of the institution, the
equipement's owner will be responsible for the replacement, and has legal
responsibility for this action.</p><p><bold>Standard 15: Duty Hours</bold></p><p><bold>Standard 15.1:</bold> The perfusionist can be hired by the hospital or
through a medical services company, respecting the labor laws according to the
signed agreement.</p><p><bold>Standard 15.2:</bold> It is briefly forbidden for the perfusionist to be
engaged to perform perfusion and perform another function in the service with
the same labor contract.</p><p><bold>Guideline 15.1</bold> The perfusionist should receive a minimum of 8 hours
of rest period for each consecutive 16-hour work period<sup>[22-24]</sup>.</p><p><bold>REFERENCES</bold></p><p>1. SBCEC: Sociedade Brasileira de Circula&#x000e7;&#x000e3;o Extracorp&#x000f3;rea.
Normas Brasileiras para o Exerc&#x000ed;cio da Especialidade de Perfusionista em
Circula&#x000e7;&#x000e3;o Extracorp&#x000f3;rea [Internet]. Campinas (SP): SBCEC;
2017 [cited 2018 Feb 08]. 54 p. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.sbcec.com.br/br/images/pdf/normas_brasileiras_cec.pdf">http://www.sbcec.com.br/br/images/pdf/normas_brasileiras_cec.pdf</ext-link></p><p>2. American Society of ExtraCorporeal Technology [Internet]. American Society of
ExtraCorporeal Technology Standards and Guidelines for Perfusion Practice
(5/23/2017) [Internet]. Chicago (IL): American Society of ExtraCorporeal
Technology; c2019 [cited 2019 Feb 08]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.amsect.org/p/cm/ld/fid=1617">http://www.amsect.org/p/cm/ld/fid=1617</ext-link></p><p>3. Minist&#x000e9;rio do Trabalho e Emprego (MT), Gabinete do Ministro. NR 32 -
Seguran&#x000e7;a e sa&#x000fa;de no trabalho em servi&#x000e7;os de sa&#x000fa;de
[Internet]. Bras&#x000ed;lia: Rep&#x000fa;blica Federativa do Brasil; 2005 [cited
2019 Feb 24]. Nov 11. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.fiocruz.br/biosseguranca/Bis/manuais/legislacao/NR-32.pdf">http://www.fiocruz.br/biosseguranca/Bis/manuais/legislacao/NR-32.pdf</ext-link></p><p>4. Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, et al. A
surgical safety checklist to reduce morbidity and mortality in a global
population. N Engl J Med. 2009 Jan 29;360(5):491-9. doi:
10.1056/NEJMsa0810119.</p><p>5. McCarthy D, Chase D, Issues Research. Advancing patient safety in the U.S.
Department of veterans affairs. Commonweath Fund [Internet]. 2011 [cited 2019
Feb 24]; 1477(9):1-32. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.commonwealthfund.org/sites/default/files/documents/___media_files_publications_case_study_2011_mar_1477_mccarthy_va_case_study_final_march_v2.pdf">https://www.commonwealthfund.org/sites/default/files/documents/___media_files_publications_case_study_2011_mar_1477_mccarthy_va_case_study_final_march_v2.pdf</ext-link></p><p>6. Workd Alliance for Patient Safety. WHO surgical safety checklist and
implementation manual [Internet]. Genova: WHO; 2008. Available from: [cited 2019
Feb 24]. HYPERLINK "<ext-link ext-link-type="uri" xlink:href="http://www.who.int/patientsafety/safesurgery/ss_checklist/en/www.who.int/patientsafety/safesurgery/ss_checklist/en/">http://www.who.int/patientsafety/safesurgery/ss_checklist/en/</ext-link>"<ext-link ext-link-type="uri" xlink:href="http://www.who.int/patientsafety/safesurgery/ss_checklist/en/www.who.int/patientsafety/safesurgery/ss_checklist/en/">www.who.int/patientsafety/safesurgery/ss_checklist/en/</ext-link></p><p>7. American College of Surgeons. Statement on distractions in the operating room
[Internet]. Chicago (IL): American College of Surgeons; Out 2016. Available
from: <ext-link ext-link-type="uri" xlink:href="https://www.facs.org/about-acs/statements/89-distractions">https://www.facs.org/about-acs/statements/89-distractions</ext-link></p><p>8. Cunha C, Moraes F, Monteiro V, Feitosa F, Silva I. Avalia&#x000e7;&#x000e3;o
microbiol&#x000f3;gica dos aparelhos celulares de profissionais do Bloco
Cir&#x000fa;rgico em um Hospital beneficente. Rev Epidemiol Control Infecc.
2016;6(3): 120-4. doi:HYPERLINK "<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17058/reci.v6i3.6717">https://doi.org/10.17058/reci.v6i3.6717</ext-link>"
10.17058/reci.v6i3.6717</p><p>9. Conselho Regional de Enfermagem de Santa Catarina (COREN). Parecer Coren/SC n.
005/CT/2015. Assunto: Uso de aparelho celular no ambiente hospitalar [Internet].
Florianopolis (SC): Coren; 2016 [cited 2019 Feb 24]. 4 p. Available from:
<ext-link ext-link-type="uri" xlink:href="http://www.corensc.gov.br/wp-content/uploads/2016/08/Parecer-T&#x000e9;cnico-005-2016-Uso-de-aparelho-celular-no-ambiente-hospitalar.pdf">http://www.corensc.gov.br/wp-content/uploads/2016/08/Parecer-T&#x000e9;cnico-005-2016-Uso-de-aparelho-celular-no-ambiente-hospitalar.pdf</ext-link></p><p>10. Wadhera RK, Parker SH, Burkhart HM, Greason KL, Neal JR, Levenick KM, et al.
Is the "sterile cockpit" concept applicable to cardiovascular surgery critical
intervals or critical events? The impact of protocol-driven communication during
cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2010 Feb;139(2):312-9. doi:
10.1016/j.jtcvs.2009.10.048.</p><p>11. Whyte S, Cartmill C, Gardezi F, Reznick R, Orser BA, Doran D, Lingard L.
Uptake of a team briefing in the operating theatre: a Burkean dramatistic
analysis. Soc Sci Med. 2009 Dec;69(12):1757-66. Doi:
10.1016/j.socscimed.2009.09.054</p><p>12. de Vries EN, Prins HA, Crolla RM, den Outer AJ, van Andel G, van Helden SH,
et al. Effect of a comprehensive surgical safety system on patient outcomes. N
Engl J Med. 2010 Nov 11;363(20):1928-37. doi: 10.1056/NEJMsa0911535.</p><p>13. Minist&#x000e9;rio da Sa&#x000fa;de (MS), Ag&#x000ea;ncia Nacional de
Vigil&#x000e2;ncia Sanit&#x000e1;ria (ANVISA). Resolu&#x000e7;ao RDC n. 302, de 13
de outubro de 2005. Disp&#x000f5;e sobre Regulamento T&#x000e9;cnico para
funcionamento de Laborat&#x000f3;rios Cl&#x000ed;nicos [Internet].
Bras&#x000ed;lia: Republica Federativa do Brasil; 2005 [cited 2019 Feb 24]. Out
14; 2005. Available from: <ext-link ext-link-type="uri" xlink:href="http://portal.anvisa.gov.br/documents/10181/2718376/RDC_302_2005_COMP.pdf/7038e853-afae-4729-948b-ef6eb3931b19">http://portal.anvisa.gov.br/documents/10181/2718376/RDC_302_2005_COMP.pdf/7038e853-afae-4729-948b-ef6eb3931b19</ext-link></p><p>14. Society of Thoracic Surgeons Blood Conservation Guideline Task Force,
Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, Song HK,
Clough ER; Society of Cardiovascular Anesthesiologists Special Task Force on
Blood Transfusion, Shore-Lesserson LJ, Goodnough LT, Mazer CD, Shander A,
Stafford-Smith M, Waters J; International Consortium for Evidence Based
Perfusion, Baker RA, Dickinson TA, FitzGerald DJ, Likosky DS, Shann KG. 2011
update to the Society of Thoracic Surgeons and the Society of Cardiovascular
Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac
Surg. 2011 Mar;91(3):944-82. doi: 10.1016/j.athoracsur.2010.11.078.</p><p>15. Nichols JH, editor. Evidence-based practice for point-of-care testing
[Internet]. Whashigton (DC): AACC; 2006 [cited 2019 Feb 24]. 203 p. Available
from: <ext-link ext-link-type="uri" xlink:href="https://www.aacc.org/SiteCollectionDocuments/NACB/LMPG/POCT/POCT%20Entire%20LMPG.pdf">https://www.aacc.org/SiteCollectionDocuments/NACB/LMPG/POCT/POCT%20Entire%20LMPG.pdf</ext-link></p><p>16. de Somer F, Mulholland JW, Bryan MR, Aloisio T, Van Nooten GJ, Ranucci M. O2
delivery and CO2 production during cardiopulmonary bypass as determinants of
acute kidney injury: time for a goal-directed perfusion management? Crit Care.
2011 Aug 10;15(4):R192. doi: 10.1186/cc10349.</p><p>17. Warren CS, DeFoe GR, Groom RC, Pieroni JW, Groski CS, Morse CB, et al.
Variation in arterial inflow temperature: a regional quality improvement
project. J Extra Corpor Technol. 2011 Jun;43(2):58-63.</p><p>18. Baker RA, Newland RF, Fenton C, McDonald M, Willcox TW, Merry AF; Perfusion
Downunder Collaboration. Developing a benchmarking process in perfusion: a
report of the Perfusion Downunder Collaboration. J Extra Corpor Technol. 2012
Mar;44(1):26-33.</p><p>19. Asociaci&#x000f3;n Espa&#x000f1;ola de Perfusionistas (AEP). Manual de Calidad
em Perfusi&#x000f3;n [Internet]. Madrid: Asociaci&#x000f3;n Espa&#x000f1;ola de
Perfusionistas (AEP); [date unknwon] [cited 2019 Feb 24]. 27 p. Available from:
<ext-link ext-link-type="uri" xlink:href="https://www.aep.es/comisiondocumentos/7/Manual_de_calidad.pdf">https://www.aep.es/comisiondocumentos/7/Manual_de_calidad.pdf</ext-link></p><p>20. Ag&#x000ea;ncia Nacional de Vigil&#x000e2;ncia Sanit&#x000e1;ria (ANVISA). Nota
T&#x000e9;cnica GVIMS/GGTES/ANVISA N.1/2005. Orienta&#x000e7;&#x000f5;es gerais
para a notifica&#x000e7;&#x000e3;o de eventos adversos relacionados &#x000e0;
assist&#x000ea;ncia &#x000e0; assist&#x000ea;ncia &#x000e0; sa&#x000fa;de. Revisada
28 de Agosto de 2018. [Internet]. Bras&#x000ed;lia: ANVISA; 2018 [cited 2019 Feb
24]. 37 p. Available from: <ext-link ext-link-type="uri" xlink:href="https://www20.anvisa.gov.br/segurancadopaciente/index.php/alertas?task=callelement&#x00026;format=raw&#x00026;item_id=419&#x00026;element=a94a4264-a31c-42d6-91d7-464889cc6e50&#x00026;method=download">https://www20.anvisa.gov.br/segurancadopaciente/index.php/alertas?task=callelement&#x00026;format=raw&#x00026;item_id=419&#x00026;element=a94a4264-a31c-42d6-91d7-464889cc6e50&#x00026;method=download</ext-link></p><p>21. Ministerio da Sa&#x000fa;de (MS), Ag&#x000ea;ncia Nacional de Vigil&#x000e2;ncia
Sanit&#x000e1;ria (ANVISA). Resolu&#x000e7;&#x000e3;o de Direotria Colegiada - RDC
n. 2, de 24 de janeiro de 2010. Disp&#x000f5;e sobre o gerenciamento de
tecnologias em sa&#x000fa;de em estabelecimentos em sa&#x000fa;de [Internet].
Brasilia: Republica Federativa do Brasil; 2010 [cited 2019 Feb 24]. Jan 26.
Available from: <ext-link ext-link-type="uri" xlink:href="http://portal.anvisa.gov.br/documents/10181/2718376/RDC_02_2010_COMP.pdf/0a8661c8-9323-4747-b103-6e83c4ff41cd">http://portal.anvisa.gov.br/documents/10181/2718376/RDC_02_2010_COMP.pdf/0a8661c8-9323-4747-b103-6e83c4ff41cd</ext-link></p><p>22. Lipschultz A. Environment of Care Essentials for Health Care. Biomed Instruct
Technol. 2012;46(5):384.</p><p>23. The Society of Clinical Perfusion Scientists of Great Britain and Ireland,
The College of Clinical Perfusion Scientists of Great Britain and Ireland.
Standards of Practice Document. Standards of practice document [Internet].
London: The Society of Clinical Perfusion Scientists of Great Britain &#x00026;
Ireland; c 2018. Available from: HYPERLINK "<ext-link ext-link-type="uri" xlink:href="http://www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40">http://www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40</ext-link>"<ext-link ext-link-type="uri" xlink:href="http://www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40">www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40</ext-link>.</p><p>24. Accreditation Council for Graduate Medical Education (ACGME). Policies and
procedures [Internet]. Chicago (IL): ACGME; Sep 29, 2018 [cited 2019 Feb 24].
Available at: <ext-link ext-link-type="uri" xlink:href="https://www.acgme.org/Portals/0/PDFs/ab_ACGMEPoliciesProcedures.pdf">https://www.acgme.org/Portals/0/PDFs/ab_ACGMEPoliciesProcedures.pdf</ext-link></p><p>*Note: "The SBCCV/SBCEC Comprehensive Standards and Guidelines for Perfusion
Practice in Brazil have been modified and adapted, following Brazilian
regulatory agencies' policies and recommendation, from The American Society of
Extracorporeal Technology (AmSECT) Standards and Guidelines[2] and translated to
Portuguese"</p></app><app id="app4"><title>Appendix A</title><p><bold>Patient Information</bold></p><list list-type="order"><list-item><p>Medical record number</p></list-item><list-item><p>Patient surname, first name</p></list-item><list-item><p>Demographics</p><p>
<list list-type="alpha-lower"><list-item><p>Age (date of birth)</p></list-item><list-item><p>Gender</p></list-item><list-item><p>Height</p></list-item><list-item><p>Weight</p></list-item><list-item><p>Body surface area (BSA)</p></list-item></list>
</p></list-item><list-item><p>Blood type</p></list-item><list-item><p>Laboratory data</p><p>
<list list-type="alpha-lower"><list-item><p>Hemoglobin/hematocrit</p></list-item><list-item><p>Predicted hematocrit on bypass</p></list-item><list-item><p>White blood cell count</p></list-item><list-item><p>Platelet count</p></list-item><list-item><p>Activated partial prothrombin time</p></list-item><list-item><p>Sodium</p></list-item><list-item><p>K+</p></list-item><list-item><p>Blood urea nitrogen/creatine</p></list-item><list-item><p>Glucose</p></list-item><list-item><p>Other relevant laboratory values</p></list-item></list>
</p></list-item><list-item><p>Patient allergies</p></list-item><list-item><p>Planned procedure</p></list-item><list-item><p>Medical history/risk factors (recommended)</p><p>
<list list-type="alpha-lower"><list-item><p>Cardiovascular</p></list-item><list-item><p>Pulmonary</p></list-item><list-item><p>Renal</p></list-item><list-item><p>Neurologic</p></list-item><list-item><p>Gastrointestinal/endocrine</p></list-item></list>
</p></list-item></list></app><app id="app5"><title>Appendix B</title><p><bold>Information Sufficient to Accurately Describe the Procedure, Personnel, and
Equipment</bold></p><list list-type="order"><list-item><p>Date of procedure</p></list-item><list-item><p>Type of procedure</p></list-item><list-item><p>Perfusionist(s) names</p></list-item><list-item><p>Surgeon(s) name</p></list-item><list-item><p>Anesthesiologist(s) name</p></list-item><list-item><p>Nurse(s) name</p></list-item><list-item><p>Operating room number</p></list-item><list-item><p>Comments/events (recommended)</p></list-item><list-item><p>Equipment</p><p>
<list list-type="alpha-lower"><list-item><p>Heart-lung machine</p></list-item><list-item><p>Cell salvage (autotransfusion) device</p></list-item><list-item><p>Heater/cooler</p></list-item></list>
</p><p>Note: Items A-C are often uniquely identified (<italic>e.g</italic>.,
Pump 1, 2, 3, etc.) The related serial numbers for each component
(<italic>e.g</italic>., roller pumps, vaporizer, blender, etc.) are
documented and stored locally.</p></list-item><list-item><p>Disposables</p><p>
<list list-type="alpha-lower"><list-item><p>Oxygenator</p></list-item><list-item><p>Cardiotomy reservoir</p></list-item><list-item><p>Tubing pack/arterial line filter</p></list-item><list-item><p>Centrifugal pump head</p></list-item><list-item><p>Cardioplegia delivery system</p></list-item><list-item><p>Cell salvage (autotransfusion)</p></list-item><list-item><p>Ultrafiltration device</p></list-item><list-item><p>Arterial cannula</p></list-item><list-item><p>Venous cannula</p></list-item><list-item><p>Cardioplegia cannulae</p></list-item><list-item><p>Sump/vent(s)</p></list-item></list>
</p><p>Note: Manufacturer, model, serial, and/or lot numbers should be
documented with items a-k.</p></list-item></list></app><app id="app6"><title>Appendix C</title><p><bold>Patient Physiological and Perfusionist Practice Parameters Documented at a
Frequency Determined by Institutional Protocol</bold></p><list list-type="order"><list-item><p>Blood flow rates (RPM)</p></list-item><list-item><p>Arterial blood pressure</p></list-item><list-item><p>Arterial line pressure</p></list-item><list-item><p>Central venous/pulmonary artery pressure</p></list-item><list-item><p>Vacuum assist venous return (VAVR)</p><p>
<list list-type="alpha-lower"><list-item><p>VAVR pressure</p></list-item><list-item><p>Venous inlet pressure (VIP)</p></list-item></list>
</p></list-item><list-item><p>Arterial/venous blood gases</p></list-item><list-item><p>Venous oxygen saturation</p></list-item><list-item><p>Patient temperatures, including:</p><p>
<list list-type="alpha-lower"><list-item><p>Patient core (at least one)</p><p><list list-type="roman-upper"><list-item><p>Nasopharyngeal</p></list-item><list-item><p>Bladder</p></list-item><list-item><p>Esophageal</p></list-item><list-item><p>Rectal</p></list-item><list-item><p>Tympanic</p></list-item><list-item><p>Myocardium (optional)</p></list-item></list></p></list-item></list>
</p></list-item><list-item><p>Cardiopulmonary bypass temperatures:</p><p>
<list list-type="roman-upper"><list-item><p>Venous return blood</p></list-item><list-item><p>Arterial blood inflow</p></list-item><list-item><p>Water bath(s) (optional)</p></list-item></list>
</p></list-item><list-item><p>Oxygenator gases including gas flow rate and concentration(s)</p></list-item><list-item><p>Input fluid volumes including:</p><p>
<list list-type="alpha-lower"><list-item><p>Prime</p></list-item><list-item><p>Blood products</p></list-item><list-item><p>Asanguineous fluids</p></list-item><list-item><p>Cardioplegic solution</p></list-item><list-item><p>Autologous components</p></list-item></list>
</p></list-item><list-item><p>Cardioplegia</p><p>
<list list-type="roman-upper"><list-item><p>Solution (ratio)</p></list-item><list-item><p>Route</p></list-item><list-item><p>Flow</p></list-item><list-item><p>Pressure</p></list-item><list-item><p>Temperature</p></list-item><list-item><p>Volume</p></list-item></list>
</p></list-item><list-item><p>Output fluid volumes, including:</p><p>
<list list-type="alpha-lower"><list-item><p>Urine output</p></list-item><list-item><p>Ultrafiltrate</p></list-item></list>
</p></list-item><list-item><p>Medications and/or inhalational anesthetic agents administered through
extracorporeal circuit</p></list-item></list></app><app id="app7"><title>Appendix D</title><p><bold>Blood Gas, Electrolyte, and Anticoagulation Monitoring Results</bold></p><list list-type="order"><list-item><p>Blood gases</p><p>
<list list-type="alpha-lower"><list-item><p>pO<sub>2</sub></p></list-item><list-item><p>pCO<sub>2</sub></p></list-item><list-item><p>pH</p></list-item><list-item><p>Base excess</p></list-item><list-item><p>Bicarbonate concentration</p></list-item><list-item><p>Saturation</p></list-item><list-item><p>Potassium concentration</p></list-item><list-item><p>Ionized calcium concentration i. Sodium concentration</p></list-item><list-item><p>Lactate</p></list-item><list-item><p>Glucose</p></list-item><list-item><p>Hemoglobin/hematocrit</p></list-item></list>
</p></list-item><list-item><p>Activated clotting times (ACTs) and/or heparin/ protamine assay results
and/or thromboelastography results.</p></list-item></list></app><app id="app8"><title>Appendix E</title><p><bold>Postoperative Evaluation of Patients Submitted to Extracorporeal
Circulation</bold></p><p>
<list list-type="order"><list-item><p>Name</p></list-item><list-item><p>Patient's hospital identification number</p></list-item><list-item><p>Date of surgery</p></list-item><list-item><p>Date/Time of ICU admission</p></list-item><list-item><p>Values of CK, CKMB and Troponin at 6hs, 12hs and 24hs</p></list-item><list-item><p>Ejection fraction in the postoperative period.</p></list-item><list-item><p>Vasoactive drugs dose used at 6hs, 12hs and 24hs</p></list-item><list-item><p>Water balance every 6 hours until completing 48 hours of ICU</p></list-item><list-item><p>Central venous pressure every 6 hours, until completing 48 hours of
ICU</p></list-item><list-item><p>Use of blood products</p></list-item><list-item><p>Extubation Time</p></list-item><list-item><p>Date of ICU discharge</p></list-item></list>
</p></app><app id="app9"><title>Appendix F</title><p><bold>Checklist</bold></p><p>The checklist should check, at least:</p><p>
<list list-type="bullet"><list-item><p>Integrity and operation of the CEC machine and heat exchanger.</p></list-item><list-item><p>Operation of gas systems and connections to the oxygenator.</p></list-item><list-item><p>Correct identification of the patient.</p></list-item><list-item><p>Availability of blood products.</p></list-item><list-item><p>Composition of the perfusate.</p></list-item><list-item><p>Composition and preparation of cardioplegia.</p></list-item><list-item><p>Cannulas that will be used.</p></list-item><list-item><p>All circuit connections.</p></list-item><list-item><p>Calibration and direction of the rollers.</p></list-item><list-item><p>Calibration of pressure, flow and bubble sensors and alarms.</p></list-item><list-item><p>Calibration of cardioplegia pressure sensors.</p></list-item><list-item><p>Calibration and connection of the gas monitor.</p></list-item><list-item><p>Availability of disposable materials and emergency equipment (hand
crank, emergency light, etc.)</p></list-item><list-item><p>Dose and administration of heparin.</p></list-item><list-item><p>Outcome of ACT before starting ECC.</p></list-item><list-item><p>Availability of drugs, needles, syringes, and serum and blood
infusion kits for use during CPB.</p></list-item></list>
</p></app><app id="app10"><title>Appendix 2</title><p><bold>SBCCV/SBCEC Padr&#x000f5;es e Diretrizes Abrangentes para a Pr&#x000e1;tica
de Perfus&#x000e3;o no Brasil*</bold></p><p><bold>Standard 1: Desenvolvimento de um protocolo institucional
pr&#x000f3;prio</bold></p><p><bold>Standard 1.1:</bold> A institui&#x000e7;&#x000e3;o ou o provedor de
servi&#x000e7;os de perfus&#x000e3;o deve desenvolver e implementar os
procedimentos operacionais padr&#x000e3;o (protocolo, POP) para cada um dos
procedimentos realizados como um mecanismo de aplica&#x000e7;&#x000e3;o das
recomenda&#x000e7;&#x000f5;es desse documento para a pr&#x000e1;tica
cl&#x000ed;nica.</p><p><bold>Standard 1.2:</bold> O protocolo dever&#x000e1; ser:</p><p>
<list list-type="bullet"><list-item><p>Aprovado pelo(a) chefe da cirurgia card&#x000ed;aca ou seu/sua
designado(a), diretor(a) da perfus&#x000e3;o ou equivalente ou outra
pessoa ou comit&#x000ea; de relev&#x000e2;ncia hier&#x000e1;rquica de
decis&#x000e3;o das pr&#x000e1;ticas cl&#x000ed;nicas
institucionais.</p></list-item><list-item><p>Revisto e reavaliado, ao menos anualmente ou com maior
frequ&#x000ea;ncia quando necess&#x000e1;rio.</p></list-item></list>
</p><p><bold>Guideline 1.1:</bold> Mudan&#x000e7;as no protocolo podem ser feitas a
crit&#x000e9;rio da Equipe Cir&#x000fa;rgica e devem ser documentadas na ficha de
perfus&#x000e3;o.</p><p><bold>Standard 2: Qualifica&#x000e7;&#x000e3;o, Compet&#x000ea;ncia e Pessoal de
Apoio</bold></p><p><bold>Standard 2.1:</bold> A circula&#x000e7;&#x000e3;o extracorp&#x000f3;rea
s&#x000f3; deve ser ralizada por profissional formado nas profiss&#x000f5;es
reconhecidas pela Sociedade Brasileira de Circula&#x000e7;&#x000e3;o
Extracorp&#x000f3;rea (SBCEC) e pela Sociedade Brasileira de Cirurgia
Cardiovasccular (SBCCV) como competentes para realizar o procedimento; ter
p&#x000f3;s-gradua&#x000e7;&#x000e3;o reconhecida pelo MEC com carga hor&#x000e1;ria
m&#x000ed;nima descrita no artigo 12 das Normas Brasileiras para o
Exerc&#x000ed;cio da Especialidade de Perfusionista em Circula&#x000e7;&#x000e3;o
Extracorp&#x000f3;rea ou T&#x000ed;tulo de Especialista da SBCEC<sup>[1]</sup>,
validado por esta Sociedade; ou profissionais que se enquadram no
par&#x000e1;grafo &#x000fa;nico do artigo 2&#x000ba; da Norma acima citada.</p><p><bold>Standard 2.2:</bold> As compet&#x000ea;ncias do perfusionista devem ser
avaliadas anualmente com o intuito de averiguar se est&#x000e3;o em conformidade
com os protocolos departamentais.</p><p><bold>Standard 2.3:</bold> O perfusionista deve assistir, participar e se
envolver em cursos de educa&#x000e7;&#x000e3;o continuada relacionados &#x000e0;
perfus&#x000e3;o ao menos uma vez ao ano.</p><p><bold>Standard 2.4:</bold> O pessoal de apoio deve estar dispon&#x000ed;vel no
local para auxiliar o perfusionista durante os procedimentos necess&#x000e1;rios
na condu&#x000e7;&#x000e3;o da CEC.</p><p><bold>Guideline 2.1:</bold> Um indiv&#x000ed;duo que se formar em um programa
credenciado de educa&#x000e7;&#x000e3;o em perfus&#x000e3;o deve preencher todos os
requisitos para a certifica&#x000e7;&#x000e3;o da SBCEC.</p><p><bold>Guideline 2.2:</bold> Um processo padronizado deve ser desenvolvido e
seguido para identificar, orientar e educar a equipe de suporte de forma a
garantir que todos tenham conhecimento geral das fun&#x000e7;&#x000f5;es
desempenhadas pelo perfusionista, fluxo cir&#x000fa;rgico e
localiza&#x000e7;&#x000e3;o dos itens essenciais e auxiliares necess&#x000e1;rios
durante a CEC. A equipe de apoio inclui equipes de perfusionistas, enfermagem,
t&#x000e9;cnicos e pessoal administrativo.</p><p><bold>Guideline 2.3:</bold> Um programa estruturado para educar, treinar e
avaliar a equipe de perfus&#x000e3;o, ao menos anualmente, deve ser desenvolvido
e seguido.</p><p><bold>Guideline 2.4:</bold> &#x000c9; recomendada a exist&#x000ea;ncia de dois
perfusionistas por procedimento, garantindo maior seguran&#x000e7;a ao
procedimento.</p><p><bold>Guideline 2.5:</bold> Utiliza&#x000e7;&#x000e3;o de equipamentos de
prote&#x000e7;&#x000e3;o individual. Durante a condu&#x000e7;&#x000e3;o da CEC o
perfusionista deve utilizar equipamentos de prote&#x000e7;&#x000e3;o individual
(EPI), como m&#x000e1;scaras, &#x000f3;culos e luvas de procedimento. As luvas
devem ser trocadas ap&#x000f3;s a coleta de amostra, ap&#x000f3;s a troca de
solu&#x000e7;&#x000e3;o (bolsa de sangue) do equipo ou sempre que estiver com
respingo de sangue<sup>[2]</sup>.</p><p><bold>Standard 3: Ficha (Registro) de Perfus&#x000e3;o</bold></p><p><bold>Standard 3.1:</bold> A ficha (registro) de perfus&#x000e3;o (escrita e/ou
eletr&#x000f4;nica) para cada procedimento de CEC deve ser inclu&#x000ed;da como
parte do prontu&#x000e1;rio m&#x000e9;dico do paciente. O registro de
perfus&#x000e3;o deve ser mantido e armazenado de acordo com a pol&#x000ed;tica da
institui&#x000e7;&#x000e3;o para a reten&#x000e7;&#x000e3;o de registros
m&#x000e9;dicos (prontu&#x000e1;rio) do paciente.</p><p><bold>Standard 3.2:</bold> A ficha (registro) deve incluir:</p><p>
<list list-type="bullet"><list-item><p>Informa&#x000e7;&#x000f5;es do paciente, incluindo dados
demogr&#x000e1;ficos e fatores de risco pr&#x000e9;-operat&#x000f3;rio
(Appendix A).</p></list-item><list-item><p>Informa&#x000e7;&#x000f5;es necess&#x000e1;rias para descrever com
precis&#x000e3;o o procedimento, pessoal e equipamento utilizado
(Appendix B).</p></list-item><list-item><p>Par&#x000e2;metros fisiol&#x000f3;gicos do paciente documentados de
acordo com a frequ&#x000ea;ncia determinada pelo protocolo
institucional (Appendix C).</p></list-item><list-item><p>Gases sangu&#x000ed;neos e resultados da monitora&#x000e7;&#x000e3;o da
anticoagula&#x000e7;&#x000e3;o (Appendix D).</p></list-item><list-item><p>o Assinatura e carimbo do perfusionista (e de todos os demais
perfusionistas de apoio) que participaram do procedimento.</p></list-item></list>
</p><p><bold>Guideline 3.1:</bold> Dever&#x000e1; haver uma ficha (registro) de
perfus&#x000e3;o (escrita e/ou eletr&#x000f4;nica) para cada procedimento de CEC.
A ficha de perfus&#x000e3;o deve incluir um espa&#x000e7;o de texto livre para
registro de coment&#x000e1;rios, incluindo ordens verbais dadas pela equipe
m&#x000e9;dica pertinentes &#x000e0; perfus&#x000e3;o realizada.</p><p><bold>Guideline 3.2:</bold> O registro de perfus&#x000e3;o deve incluir as
assinaturas do(s) m&#x000e9;dico(s) respons&#x000e1;vel(is) pela supervis&#x000e3;o
da CEC.</p><p><bold>Guideline 3.3:</bold> Os dados brutos (por exemplo, fluxo sangu&#x000ed;neo,
press&#x000e3;o e valores de temperatura) contidos em bancos de dados de
perfus&#x000e3;o eletr&#x000f4;nica devem ser armazenados por um per&#x000ed;odo de
tempo definido pela pol&#x000ed;tica institucional referente &#x000e0;
reten&#x000e7;&#x000e3;o de registros m&#x000e9;dicos eletr&#x000f4;nicos de
pacientes.</p><p><bold>Standard 4: <italic>Checklist</italic></bold></p><p><bold>Standard 4.1:</bold> O perfusionista deve utilizar um
<italic>checklist</italic> para cada perfus&#x000e3;o
realizada<sup>[4]</sup>.</p><p><bold>Standard 4.2:</bold> O <italic>checklist</italic> deve ser preenchido,
inclu&#x000ed;do e anexado ao prontu&#x000e1;rio do paciente.</p><p><bold>Guideline 4.1:</bold> O perfusionista deve fazer o
<italic>checklist</italic> lendo-o em voz alta a outro perfusionista e
marcando cada um dos itens ap&#x000f3;s a confirma&#x000e7;&#x000e3;o de que aquela
a&#x000e7;&#x000e3;o, definida item a item, foi realizada<sup>[4]</sup>. O
preenchimento do <italic>cheklist</italic> deve ser realizado por duas pessoas,
sendo uma delas o perfusionista principal respons&#x000e1;vel pela
condu&#x000e7;&#x000e3;o da CEC durante o per&#x000ed;odo intraoperat&#x000f3;rio.
Nos servi&#x000e7;os em que n&#x000e3;o h&#x000e1; a disponibilidade de outro
profissional perfusionista, deve ser adotada uma rotina sistem&#x000e1;tica de
verifica&#x000e7;&#x000e3;o dos itens contidos no <italic>checklist</italic>, com
o objetivo de minimizar a ocorr&#x000ea;ncia de eventos adversos.</p><p><bold>Guideline 4.2:</bold> O perfusionista deve utilizar o
<italic>checklist</italic> ao longo de todo o per&#x000ed;odo
perioperat&#x000f3;rio (p. ex., montagem da m&#x000e1;quina de CEC,
pr&#x000e9;-CEC, fase inicial da perfus&#x000e3;o, antes da sa&#x000ed;da da
perfus&#x000e3;o, ap&#x000f3;s a perfus&#x000e3;o e/ou qualquer retorno &#x000e0;
CEC).</p><p><bold>Guideline 4.3:</bold> O perfusionista deve utilizar o
<italic>checklist</italic> para os demais servi&#x000e7;os auxiliares
&#x000e0; perfus&#x000e3;o (isto &#x000e9;, recupera&#x000e7;&#x000e3;o
sangu&#x000ed;nea atrav&#x000e9;s de "<italic>cell salvage</italic>", bal&#x000e3;o
intra-a&#x000f3;rtico, oxigena&#x000e7;&#x000e3;o por membrana extracorp&#x000f3;rea
- <italic>extracorporeal membrane oxygenation</italic> - ECMO, entre
outros).</p><p><bold>Standard 5: Comunica&#x000e7;&#x000e3;o</bold></p><p><bold>Standard 5.1:</bold> Um plano de perfus&#x000e3;o individualizado e
especif&#x000ed;co ao paciente deve ser preparado e comunicado &#x000e0; equipe
cir&#x000fa;rgica tanto no "<italic>briefing</italic>" quanto antes do
in&#x000ed;cio do procedimento<sup>[5]</sup>.</p><p><bold>Guideline 5.1:</bold> O uso de aparelhos de telefone celular em sala
cir&#x000fa;rgica deve ser evitado e em CEC deve ser proibido, visto que &#x000e9;
um fator de distra&#x000e7;&#x000e3;o e predisponente para riscos ao paciente.
Al&#x000e9;m disso, a grande maioria est&#x000e1; contaminada por bact&#x000e9;rias
potencialmente infectantes, comprometendo a qualidade e seguran&#x000e7;a da
assist&#x000ea;ncia. Quando seu uso for inevit&#x000e1;vel, os aparelhos devem ser
higienizados previamente, conforme protocolo de antissepsia da
institui&#x000e7;&#x000e3;o<sup>[6-8]</sup>.</p><p><bold>Guideline 5.2:</bold> A comunica&#x000e7;&#x000e3;o padronizada por meio de
protocolos espec&#x000ed;ficos (p. ex., <italic>closed loop
communication</italic>) deve ser utilizada para o reconhecimento dos
comandos verbais, verifica&#x000e7;&#x000e3;o de conte&#x000fa;do e
redu&#x000e7;&#x000e3;o de ambiguidade<sup>[9-11]</sup>.</p><p><bold>Guideline 5.3:</bold> O perfusionista principal dever&#x000e1; participar do
"<italic>debrief</italic>" p&#x000f3;s-operat&#x000f3;rio com toda a equipe
cir&#x000fa;rgica.</p><p><bold>Standard 6: Dispositivos de Seguran&#x000e7;a</bold></p><p><bold>Standard 6.1:</bold> O monitoramento de press&#x000e3;o da linha arterial,
do sistema de administra&#x000e7;&#x000e3;o de cardioplegia e do
reservat&#x000f3;rio venoso (quando a drenagem venosa assistida por v&#x000e1;cuo
for utilizada) deve ser realizado e documentado durante a CEC.</p><p>
<list list-type="bullet"><list-item><p>O monitor de press&#x000e3;o deve ser servorregulado para o controle
do rolete arterial e de cardioplegia de acordo com a press&#x000e3;o
da linha arterial e da linha de cardioplegia, permitindo a
interrup&#x000e7;&#x000e3;o do fluxo de ambas.</p></list-item><list-item><p>O monitor de press&#x000e3;o deve incluir um alarme audiovisual.</p></list-item></list>
</p><p><bold>Standard 6.2:</bold> Detector de bolhas deve ser utilizado durante a
CEC.</p><p>
<list list-type="bullet"><list-item><p>O detector de macrobolhas deve ser usado para controlar a bomba
arterial ou para permitir a interrup&#x000e7;&#x000e3;o do fluxo
sangu&#x000ed;neo arterial.</p></list-item><list-item><p>O sistema detector deve incluir um alarme aud&#x000ed;vel e visual e
ser posicionado de acordo com as instru&#x000e7;&#x000f5;es do
fabricante para uso do oxigenador, ligado e testado antes de cada
procedimento, de forma a permitir a identifica&#x000e7;&#x000e3;o e
a&#x000e7;&#x000e3;o a tempo de evitar sua passagem para o
paciente.</p></list-item></list>
</p><p><bold>Standard 6.3:</bold> Um sensor de n&#x000ed;vel deve ser utilizado durante a
CEC quando utilizado um reservat&#x000f3;rio r&#x000ed;gido (<italic>hard-shell
venous reservoir</italic>) no circuito.</p><p>
<list list-type="bullet"><list-item><p>O sensor de n&#x000ed;vel deve ser servorregulado para controlar a
bomba arterial ou para permitir a interrup&#x000e7;&#x000e3;o do fluxo
sangu&#x000ed;neo arterial.</p></list-item><list-item><p>O sensor de n&#x000ed;vel deve incluir um alarme aud&#x000ed;vel e
visual e ser posicionado de acordo com as instru&#x000e7;&#x000f5;es
do fabricante para permitir um tempo de rea&#x000e7;&#x000e3;o
apropriado e um volume operacional seguro.</p></list-item></list>
</p><p><bold>Standard 6.4:</bold> O monitoramento da temperatura da sa&#x000ed;da
arterial do oxigenador deve ser utilizado durante os procedimentos de CEC.</p><p>
<list list-type="bullet"><list-item><p>O sensor de temperatura deve incluir um alarme aud&#x000ed;vel e
visual para a preven&#x000e7;&#x000e3;o de temperaturas elevada na
sa&#x000ed;da arterial do oxigenador.</p></list-item></list>
</p><p><bold>Standard 6.5:</bold> Um filtro arterial isolado ou acoplado ao oxigenador
deve ser utilizado em todo o circuito de CEC. Quando usado de forma isolada do
oxigenador, deve ser utilizado no circuito depois do oxigenador e deve contar
com uma linha de recircula&#x000e7;&#x000e3;o conectada ao reservat&#x000f3;rio de
cardiotomia ou venoso. Deve dispor de um "<italic>bypass</italic>" que permita
ao perfusionista anular o filtro em caso de obstru&#x000e7;&#x000e3;o ou
rupture.</p><p><bold>Standard 6.6:</bold> Uma v&#x000e1;lvula "<italic>one-way</italic>" deve ser
utilizada na linha de aspira&#x000e7;&#x000e3;o da aorta/&#x000e1;trio esquerdo
durante a perfus&#x000e3;o.</p><p><bold>Standard 6.7:</bold> Deve ser utilizado pelo menos um m&#x000e9;todo para
evitar o fluxo retr&#x000f3;grado para a circula&#x000e7;&#x000e3;o
sist&#x000ea;mica em circuitos com bombas centr&#x000ed;fugas. Exemplos de
sistemas de evas&#x000e3;o retr&#x000f3;grada podem incluir:</p><p>
<list list-type="bullet"><list-item><p>V&#x000e1;lvulas de fluxo unidirecional (<italic>one-way flow
valves</italic>);</p></list-item><list-item><p>Controles de redu&#x000e7;&#x000e3;o de velocidade da bomba com
mecanismos de preven&#x000e7;&#x000e3;o de acionamento acidental
(<italic>hard-stop detent controls</italic>);</p></list-item><list-item><p>Pin&#x000e7;as de acionamento eletr&#x000f4;nico na linha arterial;
ou</p></list-item><list-item><p>Alarme audiovisual em caso de baixa velocidade da bomba.</p></list-item></list>
</p><p><bold>Standard 6.8:</bold> Uma linha de elimina&#x000e7;&#x000e3;o de gases deve
ser utilizada sempre que anest&#x000e9;sicos inalat&#x000f3;rios forem utilizados
diretamente no circuito durante a perfus&#x000e3;o.</p><p><bold>Standard 6.9:</bold> Manivelas manuais (<italic>hand cranks</italic>) devem
estar prontamente dispon&#x000ed;veis durante a perfus&#x000e3;o.</p><p><bold>Standard 6.10:</bold>
<italic>Backups</italic> (alternativas de seguran&#x000e7;a) de fonte de
g&#x000e1;s (p. ex., cilindro de oxig&#x000ea;nio/ar comprimido) devem estar
prontamente dispon&#x000ed;veis durante a CEC.</p><p><bold>Standard 6.11:</bold> A m&#x000e1;quina de CEC deve possuir bateria
incorporada ou outra fonte de energia suplementar dispon&#x000ed;vel durante toda
a perfus&#x000e3;o.</p><p><bold>Guideline 6.1:</bold> Um analisador de oxig&#x000ea;nio da mistura de
g&#x000e1;s (<italic>sweep flow</italic>) antes da entrada de g&#x000e1;s da
membrana deve ser utilizado durante a perfus&#x000e3;o.</p><p><bold>Guideline 6.2:</bold> Um sensor de n&#x000ed;vel deve ser usado durante os
procedimentos de CPB com um reservat&#x000f3;rio fechado (<italic>soft-shell
reservoir</italic>).</p><p>
<list list-type="bullet"><list-item><p>O sensor de n&#x000ed;vel deve ser servorregulado para controlar a
bomba arterial ou para permitir a interrup&#x000e7;&#x000e3;o do fluxo
sangu&#x000ed;neo arterial.</p></list-item><list-item><p>O sensor de n&#x000ed;vel deve incluir um alarme sonoro e visual e ser
posicionado de acordo com as instru&#x000e7;&#x000f5;es do fabricante
para permitir um tempo de rea&#x000e7;&#x000e3;o apropriado e um
volume operacional seguro.</p></list-item><list-item><p>O uso de um detector de bolhas de ar distal &#x000e0; sa&#x000ed;da do
reservat&#x000f3;rio pode ser utilizado em substitui&#x000e7;&#x000e3;o
ao detector de n&#x000ed;vel.</p></list-item></list>
</p><p><bold>Guideline 6.3:</bold> A bandeja de tubos disponibilizados para montagem do
circuito deve ser disponibilizada "pr&#x000e9;-montada", pr&#x000e9;-conectada e
em bandeja est&#x000e9;ril separando o circuito que ficar&#x000e1; no campo
cir&#x000fa;rgico daquele que ficar&#x000e1; na m&#x000e1;quina de CEC, ofertando
mais seguran&#x000e7;a ao procedimento e gerando mais rapidez na montagem do
circuito.</p><p><bold>Standard 7: Monitora&#x000e7;&#x000e3;o (obs.: para ser realizado em conjunto
com Standard 3)</bold></p><p><bold>Standard 7.1:</bold> A press&#x000e3;o arterial do paciente deve ser
monitorada de forma cont&#x000ed;nua durante toda a CEC.</p><p><bold>Standard 7.2:</bold> A press&#x000e3;o da linha arterial do circuito de CEC
deve ser monitorada durante toda a perfus&#x000e3;o.</p><p><bold>Standard 7.3:</bold> O fluxo arterial deve ser monitorado continuamente
durante toda a perfus&#x000e3;o.</p><p><bold>Standard 7.4:</bold> A dose de cardioplegia, o m&#x000e9;todo de
infus&#x000e3;o, a press&#x000e3;o de linha (cardioplegia anter&#x000f3;grada), a
press&#x000e3;o do seio coron&#x000e1;rio (cardioplegia retr&#x000f3;grada) e os
intervalos de isquemia devem ser continuamente monitorados durante a CEC.</p><p><bold>Standard 7.5:</bold> A temperatura do paciente e dos dispositivos deve ser
continuamente monitorada durante a CEC.</p><p>
<list list-type="bullet"><list-item><p>Paciente: nasofar&#x000ed;ngea, retal, vesical, esof&#x000e1;gica.</p></list-item><list-item><p>M&#x000e1;quina de CEC: arterial, venosa e cardioplegia.</p></list-item><list-item><p>Trocador de calor (<italic>heater-cooler</italic>): temperatura da
&#x000e1;gua.</p></list-item></list>
</p><p><bold>Standard 7.6:</bold> A an&#x000e1;lise de gases sangu&#x000ed;neos
(gasometria) deve ser monitorada continuamente ou em intervalos regulares
durante a CEC (Appendix D).</p><p><bold>Standard 7.7:</bold> O hemat&#x000f3;crito (ou hemoglobina) deve ser
monitorado continuamente durante a CEC.</p><p><bold>Standard 7.8:</bold> A fra&#x000e7;&#x000e3;o de oxig&#x000ea;nio
(FiO<sub>2</sub>) e o fluxo de g&#x000e1;s (<italic>sweep flow</italic>)
devem ser monitorados continuamente durante a CEC (Appendix D).</p><p><bold>Standard 7.9:</bold> A porcentagem de oclus&#x000e3;o da linha venosa do
oclusor venoso (<italic>clamp</italic> venoso automatizado), quando
dispon&#x000ed;vel, deve ser monitorada continuamente durante a CEC.</p><p><bold>Standard 7.10:</bold> Satura&#x000e7;&#x000e3;o venosa de oxig&#x000ea;nio
deve ser monitorada continuamente ou em intervalos regulares durante a CEC.</p><p><bold>Guideline 7.1:</bold> A remo&#x000e7;&#x000e3;o de CO<sub>2</sub>
(etCO<sub>2</sub> ou pCO<sub>2</sub>) deve ser continuamente monitorada
durante a CEC.</p><p><bold>Guideline 7.2:</bold> A satura&#x000e7;&#x000e3;o arterial de oxig&#x000ea;nio
(SaO<sub>2</sub>) deve ser continuamente monitorada durante a CEC.</p><p><bold>Guideline 7.3:</bold> As seguintes press&#x000f5;es do paciente devem ser
monitoradas durante a CEC:</p><p>
<list list-type="bullet"><list-item><p>Press&#x000e3;o venosa central (PVC); e/ou</p></list-item><list-item><p>Press&#x000e3;o da art&#x000e9;ria pulmonar.</p></list-item></list>
</p><p><bold>Guideline 7.4:</bold> Os gases sangu&#x000ed;neos devem ser continuamente
monitorados (in-line) durante a CEC.</p><p><bold>Guideline 7.5:</bold> A oximetria cerebral (NIRS) deve ser utilizada
durante a CEC sempre que d&#x000ed;spon&#x000ed;vel.</p><p><bold>Guideline 7.6:</bold> O fluxo sangu&#x000ed;neo arterial deve ser monitorado
continuamente em um ponto no circuito no qual reflete com precis&#x000e3;o o
fluxo entregue ao paciente durante a CEC (p. ex., distal &#x000e0; "<italic>purge
line</italic>").</p><p><bold>Standard 8: Anticoagula&#x000e7;&#x000e3;o</bold></p><p><bold>Standard 8.1:</bold> O perfusionista, em colabora&#x000e7;&#x000e3;o com o
cirurgi&#x000e3;o respons&#x000e1;vel, deve definir o algoritmo pretendido para o
manejo da anticoagula&#x000e7;&#x000e3;o (heparina) e um algoritmo alternativo
para a hepariniza&#x000e7;&#x000e3;o n&#x000e3;o adequada, incluindo intervalos
aceit&#x000e1;veis para o tempo de coagula&#x000e7;&#x000e3;o ativada (TCA).</p><p><bold>Standard 8.2:</bold> O perfusionista deve trabalhar em estreita
colabora&#x000e7;&#x000e3;o com a equipe de cuidados cir&#x000fa;rgicos na
monitora&#x000e7;&#x000e3;o e no tratamento do estado de coagula&#x000e7;&#x000e3;o
do paciente antes, durante e ap&#x000f3;s a CEC.</p><p><bold>Guideline 8.1:</bold> A equipe cir&#x000fa;rgica deve determinar o alvo do
TCA considerando fatores relevantes, incluindo variabilidade em sua medida
atribu&#x000ed;da &#x000e0;s caracter&#x000ed;sticas de desempenho do
dispositivo.</p><p><bold>Guideline 8.2:</bold> A dose inicial de heparina espec&#x000ed;fica para o
paciente deve ser determinada por um dos seguintes m&#x000e9;todos:</p><p>
<list list-type="bullet"><list-item><p>Peso;</p></list-item><list-item><p>Curva de dose-resposta (automatizada ou manual);</p></list-item><list-item><p>Volume sangu&#x000ed;neo; ou</p></list-item><list-item><p>Superf&#x000ed;cie corp&#x000f3;rea.</p></list-item></list>
</p><p><bold>Guideline 8.3:</bold> O monitoramento da anticoagula&#x000e7;&#x000e3;o deve
incluir o TCA, devendo-se realizar um TCA inicial, outro ap&#x000f3;s a protamina
e, durante a CEC, pelo menos um a cada 30 minutos. Testes de monitoramento
adicionais podem incluir:</p><p>
<list list-type="bullet"><list-item><p>N&#x000ed;vel de heparina (p. ex., titula&#x000e7;&#x000e3;o de
heparina/protamina ou n&#x000ed;vel de heparina n&#x000e3;o
fracionado);</p></list-item><list-item><p>Tempo de tromboplastina parcial ativada (TTPa);</p></list-item><list-item><p>Tromboelastograma;</p></list-item><list-item><p>Tempo de trombina (TP); e/ou</p></list-item><list-item><p>Anti-Xa.</p></list-item></list>
</p><p>A execu&#x000e7;&#x000e3;o dos testes laboratoriais remotos - TLR
(<italic>point-of-care</italic>) deve estar vinculada a um
laborat&#x000f3;rio cl&#x000ed;nico do hospital. O respons&#x000e1;vel
t&#x000e9;cnico pelo laborat&#x000f3;rio cl&#x000ed;nico &#x000e9;
respons&#x000e1;vel por todos os TLR realizados dentro da
institui&#x000e7;&#x000e3;o. O laborat&#x000f3;rio cl&#x000ed;nico deve
disponibilizar, nos locais de realiza&#x000e7;&#x000e3;o de TLR, procedimentos
documentados com orienta&#x000e7;&#x000f5;es sobre suas fases
pr&#x000e9;-anal&#x000ed;tica, anal&#x000ed;tica e p&#x000f3;s-anal&#x000ed;tica,
incluindo:</p><p>
<list list-type="alpha-lower"><list-item><p>Sistem&#x000e1;tica de registro e libera&#x000e7;&#x000e3;o de
resultados provis&#x000f3;rios.</p></list-item><list-item><p>Procedimento para resultados potencialmente cr&#x000ed;ticos.</p></list-item><list-item><p>Sistem&#x000e1;tica de revis&#x000e3;o de resultados e
libera&#x000e7;&#x000e3;o de laudos por profissional habilitado.</p></list-item></list>
</p><p>O laborat&#x000f3;rio cl&#x000ed;nico deve manter registros dos controles da
qualidade, bem como procedimentos para sua realiza&#x000e7;&#x000e3;o.O
laborat&#x000f3;rio cl&#x000ed;nico deve promover e manter registros de seu
processo de educa&#x000e7;&#x000e3;o permanente para os usu&#x000e1;rios dos
equipamentos de TLR<sup>[12]</sup>.</p><p><bold>Guideline 8.4:</bold> As doses adicionais de heparina durante a CEC devem
ser determinadas usando a titula&#x000e7;&#x000e3;o pelo TCA e/ou
heparina/protamina. Nota: em pacientes que requerem tempos de CEC mais longos
(&#x0003e; 2 a 3 horas), pode-se considerer a manuten&#x000e7;&#x000e3;o de
concentra&#x000e7;&#x000f5;es de heparina mais altas e/ou espec&#x000ed;ficas para
o paciente durante a CEC, para reduzir a ativa&#x000e7;&#x000e3;o do sistema de
coagula&#x000e7;&#x000e3;o e o consumo de plaquetas e prote&#x000ed;nas de
coagula&#x000e7;&#x000e3;o, assim como evitar ou reduzir a transfus&#x000e3;o de
hemoderivados (Classe IIb, N&#x000ed;vel de evid&#x000ea;ncia
B)<sup>[13]</sup>.</p><p><bold>Guideline 8.5:</bold> A revers&#x000e3;o da heparina deve ser confirmada por
TCA, tromboelastrograma e/ou titula&#x000e7;&#x000e3;o da heparina/protamina.</p><p><bold>Standard 9: Manuseio transfusional</bold></p><p><bold>Standard 9.1:</bold> O perfusionista deve aderir &#x000e0;s pr&#x000e1;ticas
recomendadas para minimizar a hemodilui&#x000e7;&#x000e3;o e evitar
transfus&#x000f5;es de sangue desnecess&#x000e1;rias<sup>[13]</sup>.</p><p><bold>Standard 9.2:</bold> O perfusionista deve minimizar o tamanho do circuito
de CEC no intuito de reduzir o volume do <italic>prime</italic>
<sup>[13]</sup>.</p><p><bold>Standard 9.3:</bold> O perfusionista deve calcular e comunicar &#x000e0;
equipe cir&#x000fa;rgica o hemat&#x000f3;crito/hemoglobina p&#x000f3;s-dilucional
previsto para o paciente antes de iniciar a CEC.</p><p><bold>Guideline 9.1:</bold> As defini&#x000e7;&#x000f5;es dos protocolos de
transfus&#x000e3;o de hemoderivados (<italic>patient blood management</italic> -
PBM) devem incluir<sup>[13]</sup>:</p><p>
<list list-type="bullet"><list-item><p>Participa&#x000e7;&#x000e3;o do perfusionista nas discuss&#x000f5;es
(<italic>briefings</italic>) pr&#x000e9;-operat&#x000f3;rias com
toda a equipe cir&#x000fa;rgica (Standard 5.1) em
rela&#x000e7;&#x000e3;o &#x000e0;s estrat&#x000e9;gias de
transfus&#x000e3;o e valores "alvos" de hemat&#x000f3;crito.</p></list-item><list-item><p>Participa&#x000e7;&#x000e3;o do perfusionista no grupo multidisciplinar
de PBM.</p></list-item></list>
</p><p>Minimizar a hemodiliu&#x000e7;&#x000e3;o por meio de:</p><p>
<list list-type="bullet"><list-item><p>Sele&#x000e7;&#x000e3;o do tamanho do circuito de CEC compat&#x000ed;vel
com o tamanho do paciente.</p></list-item><list-item><p>Preenchimento do circuito com sangue aut&#x000f3;logo, incluindo
enchimento retr&#x000f3;grado do circuito com sangue
(<italic>retrograde autologous priming</italic> - RAP).</p></list-item><list-item><p>Utiliza&#x000e7;&#x000e3;o de tubos com revestimento
biocompat&#x000ed;vel/bioativos em todos os componentes de CEC.</p></list-item><list-item><p>Recupera&#x000e7;&#x000e3;o perioperat&#x000f3;ria de c&#x000e9;lulas
sangu&#x000ed;neas (<italic>cell savage</italic>) e reinfus&#x000e3;o
ap&#x000f3;s processamento adequado.</p></list-item><list-item><p>Recupera&#x000e7;&#x000e3;o do sangue do circuito de CEC ao final do
procedimento ("<italic>blood cell savage</italic>" do
"<italic>prime</italic>" do circuito).</p></list-item></list>
</p><p><bold>Guideline 9.2:</bold> Monitora&#x000e7;&#x000e3;o da hemostasia por meio de
"<italic>point-of-care</italic>" deve ser utilizada na
minimiza&#x000e7;&#x000e3;o da perda sangu&#x000ed;nea.</p><p>Essa monitora&#x000e7;&#x000e3;o deve incluir:</p><p>
<list list-type="bullet"><list-item><p><italic>International normalized ratio</italic> (INR ou RNI);</p></list-item><list-item><p>Tempo de tromboplastina parcial ativada (TTPa);</p></list-item><list-item><p>Tempo de protrombina (TP);</p></list-item><list-item><p>Tempo de trombina (TT);</p></list-item><list-item><p>Tromboelastograma;</p></list-item><list-item><p>Contagem de plaquetas; e/ou</p></list-item><list-item><p>Agrega&#x000e7;&#x000e3;o plaquet&#x000e1;ria.</p></list-item></list>
</p><p><bold>Standard 10: Troca Gasosa</bold></p><p><bold>Standard 10.1:</bold> A troca de g&#x000e1;s deve ser mantida durante a CEC
de acordo com o protocolo, considerando:</p><p>
<list list-type="bullet"><list-item><p>Caracter&#x000ed;sticas individuais do paciente e perfil de risco;</p></list-item><list-item><p>Tipo de oxigenador, <italic>design</italic> e
instru&#x000e7;&#x000f5;es de uso; e</p></list-item><list-item><p>Fluxo sangu&#x000ed;neo, temperatura e demanda metab&#x000f3;lica.</p></list-item></list>
</p><p><bold>Standard 10.2:</bold> Os dispositivos utilizados para medir a troca gasosa
devem ser calibrados de acordo com as instru&#x000e7;&#x000f5;es de uso do
fabricante.</p><p><bold>Standard 10.3:</bold> A an&#x000e1;lise sangu&#x000ed;nea dos gases
(gasometria) deve ser realizada e anotada de acordo com o protocolo.</p><p><bold>Guideline 10.1:</bold> Exames realizados com dispositivos
"<italic>point-of-care</italic>" devem ser considerados para propiciar
informa&#x000e7;&#x000f5;es precisas e instant&#x000e2;neas para an&#x000e1;lise de
gases no sangue<sup>[14]</sup>.</p><p><bold>Guideline 10.2:</bold> O c&#x000e1;lculo da oferta e consumo de
oxig&#x000ea;nio deve ser utilizado para avaliar e otimizar a troca
gasosa<sup>[15]</sup>:</p><p>Oferta de oxig&#x000ea;nio: DO<sub>2</sub> = 10 x IC x CaO<sub>2</sub></p><p>Consumo de oxig&#x000ea;nio: VO<sub>2</sub> = 10 x IC x (CaO<sub>2</sub> -
CvO<sub>2</sub>)</p><p>Em que:</p><p>CaO<sub>2</sub> (conte&#x000fa;do de oxig&#x000ea;nio arterial) = (Hb x 1,36 x
SaO<sub>2</sub>) + (0,0031 x PaO<sub>2</sub>)</p><p>e</p><p>CvO<sub>2</sub> (conte&#x000fa;do de oxig&#x000ea;nio venoso misto) = (Hb x 1,36 x
SvO<sub>2</sub>) + (0,0031 x PvO<sub>2</sub>)</p><p>HB = hemoglobina</p><p>IC = &#x000ed;ndice card&#x000ed;aco</p><p>PaO<sub>2</sub> = press&#x000e3;o parcial de oxig&#x000ea;nio no sangue
arterial</p><p>PvO<sub>2</sub> = press&#x000e3;o parcial de oxig&#x000ea;nio no sangue venoso</p><p>SaO<sub>2</sub> = satura&#x000e7;&#x000e3;o arterial de oxig&#x000ea;nio</p><p>SvO<sub>2</sub> = satura&#x000e7;&#x000e3;o venosa de oxig&#x000ea;nio</p><p><bold>Standard 11: Fluxo de perfus&#x000e3;o</bold></p><p><bold>Standard 11.1:</bold> O fluxo de perfus&#x000e3;o alvo deve ser determinado
antes de iniciar a CEC de acordo com o protocolo institucional. Obs.:
superf&#x000ed;cie corp&#x000f3;rea x &#x000ed;ndice card&#x000ed;aco = fluxo
sangu&#x000ed;neo calculado, no qual a superf&#x000ed;cie corp&#x000f3;rea em
metros quadrados &#x000e9; igual &#x000e0; raiz quadrada da altura vezes o peso
dividido por 3.600 (&#x0221a;altura &#x000d7; peso/3.600), utilizando altura em
cent&#x000ed;metros (cm) e peso em kilogramas (kg).</p><p><bold>Standard 11.2:</bold> O perfusionista deve trabalhar em estreita
colabora&#x000e7;&#x000e3;o com a equipe cir&#x000fa;rgica na
manuten&#x000e7;&#x000e3;o da taxa de fluxo sangu&#x000ed;neo definido/calculado
durante a CEC.</p><p><bold>Guideline 11.1:</bold> As varia&#x000e7;&#x000f5;es do fluxo sangu&#x000ed;neo
definido/calculado devem ser comunicadas ao m&#x000e9;dico/cirurgi&#x000e3;o
respons&#x000e1;vel.</p><p><bold>Guideline 11.2:</bold> O fluxo de perfus&#x000e3;o adequado deve ser
definido pela avalia&#x000e7;&#x000e3;o de:</p><p>
<list list-type="bullet"><list-item><p>Balan&#x000e7;o &#x000e1;cido-base;</p></list-item><list-item><p>Excesso de bases (BE);</p></list-item><list-item><p>N&#x000ed;vel anest&#x000e9;sico;</p></list-item><list-item><p>Press&#x000e3;o sanguinea arterial;</p></list-item><list-item><p>Oximetria cerebral (NIRS);</p></list-item><list-item><p>N&#x000ed;vel de lactato;</p></list-item><list-item><p>Entrega e consumo de oxig&#x000ea;nio (observar a f&#x000f3;rmula no
Guideline 10.2);</p></list-item><list-item><p>pO<sub>2</sub> venosa;</p></list-item><list-item><p>pO<sub>2</sub> arterial;</p></list-item><list-item><p>Concentra&#x000e7;&#x000e3;o de hemoglobina;</p></list-item><list-item><p>Satura&#x000e7;&#x000e3;o arterial de oxig&#x000ea;nio;</p></list-item><list-item><p>Resist&#x000ea;ncia vascular sist&#x000ea;mica;</p></list-item><list-item><p>Temperatura; e</p></list-item><list-item><p>Satura&#x000e7;&#x000e3;o venosa de oxig&#x000ea;nio
(SaVO<sub>2</sub>).</p></list-item></list>
</p><p><bold>Standard 12: Press&#x000e3;o arterial</bold></p><p><bold>Standard 12.1:</bold> O perfusionista, em conjunto com o
m&#x000e9;dico/cirurgi&#x000e3;o respons&#x000e1;vel, deve definir e comunicar o
algoritmo de tratamento pretendido para o gerenciamento da press&#x000e3;o
arterial antes da CEC, incluindo seus n&#x000ed;veis aceit&#x000e1;veis. Obs.: em
muitas circunst&#x000e2;ncias, o m&#x000e9;dico respons&#x000e1;vel pode direcionar
o perfusionista para modificar a administra&#x000e7;&#x000e3;o da press&#x000e3;o
arterial pretendida para atender &#x000e0;s circunst&#x000e2;ncias que ocorrem
durante o procedimento de CEC.</p><p><bold>Standard 12.2:</bold> O perfusionista deve trabalhar em conjunto com a
equipe cir&#x000fa;rgica para manter a press&#x000e3;o arterial de acordo com os
protocolos da CEC.</p><p><bold>Guideline 12.1:</bold> A varia&#x000e7;&#x000e3;o entre a press&#x000e3;o
arterial definida/calculada e a atingida deve ser documentada e comunicada ao
m&#x000e9;dico respons&#x000e1;vel para permitir altera&#x000e7;&#x000f5;es no plano
de manejo da press&#x000e3;o arterial.</p><p><bold>Standard 13: Avalia&#x000e7;&#x000e3;o e Melhorias na Qualidade</bold></p><p><bold>Standard 13.1:</bold> O perfusionista deve participar ativamente dos
programas institucionais e departamentais de controle e melhoria da
qualidade.</p><p><bold>Guideline 13.1:</bold> O perfusionista deve coletar dados relativos
&#x000e0; condu&#x000e7;&#x000e3;o da perfus&#x000e3;o por meio de um registro
cl&#x000ed;nico ou banco de dados.</p><p><bold>Guideline 13.2:</bold> O perfusionista deve usar esses dados para projetos
de controle e melhoria de qualidade<sup>[16,17]</sup>.</p><p><bold>Guideline13.3:</bold> O perfusionista deve avaliar em ficha padr&#x000e3;o
(Appendix E) o p&#x000f3;s-operat&#x000f3;rio do paciente, armazendo dados para
avalia&#x000e7;&#x000f5;es peri&#x000f3;dicas da perfus&#x000e3;o no
servi&#x000e7;o<sup>[18]</sup>.</p><p><bold>Guideline 13.4:</bold> Reuni&#x000f5;es espec&#x000ed;ficas e
peri&#x000f3;dicas devem ser realizadas para a revisao de erros evit&#x000e1;veis
que ocorram no servi&#x000e7;o.</p><p><bold>Guideline 13.5:</bold> Todo e qualquer evento adverso deve ser notificado
por escrito ao setor respons&#x000e1;vel, o qual dar&#x000e1; encaminhamento
&#x000e0;s ag&#x000ea;ncias regulat&#x000f3;rias e demais org&#x000e3;os competentes
ap&#x000f3;s apura&#x000e7;&#x000e3;o. O servi&#x000e7;o deve incentivar a
realiza&#x000e7;&#x000e3;o constante das notifica&#x000e7;&#x000f5;es, estabelecendo
uma linha de comunica&#x000e7;&#x000e3;o direta entre a equipe e a ger&#x000ea;ncia
de risco, garantindo seu sigilo<sup>[19]</sup>.</p><p><bold>Standard 14: Manuten&#x000e7;&#x000e3;o</bold></p><p><bold>Standard 14.1:</bold> O perfusionista deve assegurar que o equipamento
utilizado na condu&#x000e7;&#x000e3;o da CEC tenha sua manuten&#x000e7;&#x000e3;o
corretamente realizada e em perfeito estado de funcionamento, incluindo (mas
n&#x000e3;o limitado a):</p><p>
<list list-type="bullet"><list-item><p>M&#x000e1;quina de CEC</p></list-item><list-item><p>Bombas</p></list-item><list-item><p>Timers</p></list-item><list-item><p>Monitores de press&#x000e3;o</p></list-item><list-item><p>Monitores de temperature</p></list-item><list-item><p>Alarme de n&#x000ed;vel</p></list-item><list-item><p>Detector de ar/bolhas</p></list-item><list-item><p>Sensores de fluxo sangu&#x000ed;neo</p></list-item><list-item><p>Trocador de calor (<italic>heater-cooler</italic>)</p></list-item><list-item><p>Vaporizador de anest&#x000e9;sico</p></list-item><list-item><p>Misturador de gases e flux&#x000f4;metro</p></list-item><list-item><p>Analisador de oxig&#x000ea;nio</p></list-item><list-item><p>Equipamentos auxiliaries</p></list-item><list-item><p>Press&#x000e3;o intra-arterial</p></list-item><list-item><p>Dispositivos de assist&#x000ea;ncia circulat&#x000f3;ria</p></list-item><list-item><p>Dispositivos de recupera&#x000e7;&#x000e3;o sangu&#x000ed;nea
(<italic>cell salvage device</italic>)</p></list-item></list>
</p><p><bold>Standard 14.2:</bold> A manuten&#x000e7;&#x000e3;o preventiva do equipamento
de perfus&#x000e3;o deve ser realizada e documentada de forma regular pela equipe
de perfus&#x000e3;o e/ou equipe de engenharia biom&#x000e9;dica apropriadamente
treinada e qualificada.</p><p>Qualquer um ou todos os seguintes itens pode determinar o intervalo dessa
manuten&#x000e7;&#x000e3;o:</p><p>
<list list-type="bullet"><list-item><p>Recomenda&#x000e7;&#x000f5;es do fabricante;</p></list-item><list-item><p>Recomenda&#x000e7;&#x000f5;noes das ag&#x000ea;ncias de
acredita&#x000e7;&#x000e3;o; e/ou</p></list-item><list-item><p>Protocolos institucionais.</p></list-item></list>
</p><p><bold>Obs.:</bold> em equipamentos consignados, o propriet&#x000e1;rio da
m&#x000e1;quina de CEC &#x000e9; respons&#x000e1;vel pela manuten&#x000e7;&#x000e3;o
no equipamento de perfus&#x000e3;o, e todas as responsabilidades e
quest&#x000f5;es legais ser&#x000e3;o imputadas a ele. Em caso de evento adverso
decorrente do uso deste equipamento, quando comprovada falha, mesmo com provas
de manuten&#x000e7;&#x000e3;o adequada e n&#x000e3;o relacionada ao uso indevido
por parte do perfusionista, o dono do equipamento, e n&#x000e3;o a
institui&#x000e7;&#x000e3;o, dever&#x000e1; ser responsabilizado.</p><p>Portanto, deve existir um documento atualizado para cada um dos equipamentos
utilizados, com as datas e os detalhes de manuten&#x000e7;&#x000e3;o preventiva e
corretivas e que deve ser arquivado na unidade de perfus&#x000e3;o ou de
engenharia cl&#x000ed;nica da institui&#x000e7;&#x000e3;o<sup>[20]</sup>.</p><p><bold>Standard 14.3:</bold> A institui&#x000e7;&#x000e3;o deve ter o procedimento
padr&#x000e3;o por escrito documentando as falhas potenciais e ocorridas no
equipamento de perfus&#x000e3;o, bem como as condutas a serem adotadas ou
corre&#x000e7;&#x000f5;es implementadas<sup>[21]</sup>.</p><p><bold>Standard 14.4:</bold> Os suprimentos necess&#x000e1;rios de perfus&#x000e3;o
de "<italic>backup</italic>" devem estar prontamente dispon&#x000ed;veis.</p><p><bold>Obs.:</bold> quando a m&#x000e1;quina de CEC n&#x000e3;o &#x000e9; propriedade
da institui&#x000e7;&#x000e3;o (em caso de equipamento consignado), o
propriet&#x000e1;rio do equipamento ser&#x000e1; respons&#x000e1;vel pela
substitui&#x000e7;&#x000e3;o e ter&#x000e1; responsabilidade legal em caso de
evento adverso decorrente do uso deste equipamento, quando comprovada falha
n&#x000e3;o relacionada ao uso indevido por parte do perfusionista.</p><p><bold>Standard 15: Horas de Servi&#x000e7;o</bold></p><p><bold>Standard 15.1:</bold> O perfusionista pode ser contratado pelo hospital ou
por empresa de servi&#x000e7;os m&#x000e9;dicos, respeitando as leis trabalhistas
de acordo com o v&#x000ed;nculo firmado.</p><p><bold>Standard 15.2:</bold> &#x000c9; sumariamente proibido que o perfusionista
seja contratado para realizar perfus&#x000e3;o e exer&#x000e7;a outra
fun&#x000e7;&#x000e3;o no servi&#x000e7;o com o mesmo contrato trabalhista.</p><p><bold>Guideline 15.1:</bold> O perfusionista deve ter um m&#x000ed;nimo de 8 horas
de per&#x000ed;odo de descanso para cada per&#x000ed;odo de trabalho consecutivo
de 16 horas<sup>[22-24]</sup>.</p><p><bold>REFERENCES</bold></p><p>1. SBCEC: Sociedade Brasileira de Circula&#x000e7;&#x000e3;o Extracorp&#x000f3;rea.
Normas Brasileiras para o Exerc&#x000ed;cio da Especialidade de Perfusionista em
Circula&#x000e7;&#x000e3;o Extracorp&#x000f3;rea [Internet]. Campinas (SP): SBCEC;
2017 [cited 2018 Feb 08]. 54 p. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.sbcec.com.br/br/images/pdf/normas_brasileiras_cec.pdf">http://www.sbcec.com.br/br/images/pdf/normas_brasileiras_cec.pdf</ext-link></p><p>2. American Society of ExtraCorporeal Technology [Internet]. American Society of
ExtraCorporeal Technology Standards and Guidelines for Perfusion Practice
(5/23/2017) [Internet]. Chicago (IL): American Society of ExtraCorporeal
Technology; c2019 [cited 2019 Feb 08]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.amsect.org/p/cm/ld/fid=1617">http://www.amsect.org/p/cm/ld/fid=1617</ext-link></p><p>3. Minist&#x000e9;rio do Trabalho e Emprego (MT), Gabinete do Ministro. NR 32 -
Seguran&#x000e7;a e sa&#x000fa;de no trabalho em servi&#x000e7;os de sa&#x000fa;de
[Internet]. Bras&#x000ed;lia: Rep&#x000fa;blica Federativa do Brasil; 2005 [cited
2019 Feb 24]. Nov 11. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.fiocruz.br/biosseguranca/Bis/manuais/legislacao/NR-32.pdf">http://www.fiocruz.br/biosseguranca/Bis/manuais/legislacao/NR-32.pdf</ext-link></p><p>4. Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, et al. A
surgical safety checklist to reduce morbidity and mortality in a global
population. N Engl J Med. 2009 Jan 29;360(5):491-9. doi:
10.1056/NEJMsa0810119.</p><p>5. McCarthy D, Chase D, Issues Research. Advancing patient safety in the U.S.
Department of veterans affairs. Commonweath Fund [Internet]. 2011 [cited 2019
Feb 24]; 1477(9):1-32. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.commonwealthfund.org/sites/default/files/documents/___media_files_publications_case_study_2011_mar_1477_mccarthy_va_case_study_final_march_v2.pdf">https://www.commonwealthfund.org/sites/default/files/documents/___media_files_publications_case_study_2011_mar_1477_mccarthy_va_case_study_final_march_v2.pdf</ext-link></p><p>6. Workd Alliance for Patient Safety. WHO surgical safety checklist and
implementation manual [Internet]. Genova: WHO; 2008. Available from: [cited 2019
Feb 24]. HYPERLINK "<ext-link ext-link-type="uri" xlink:href="http://www.who.int/patientsafety/safesurgery/ss_checklist/en/www.who.int/patientsafety/safesurgery/ss_checklist/en/">http://www.who.int/patientsafety/safesurgery/ss_checklist/en/</ext-link>"<ext-link ext-link-type="uri" xlink:href="http://www.who.int/patientsafety/safesurgery/ss_checklist/en/www.who.int/patientsafety/safesurgery/ss_checklist/en/">www.who.int/patientsafety/safesurgery/ss_checklist/en/</ext-link></p><p>7. American College of Surgeons. Statement on distractions in the operating room
[Internet]. Chicago (IL): American College of Surgeons; Out 2016. Available
from: <ext-link ext-link-type="uri" xlink:href="https://www.facs.org/about-acs/statements/89-distractions">https://www.facs.org/about-acs/statements/89-distractions</ext-link></p><p>8. Cunha C, Moraes F, Monteiro V, Feitosa F, Silva I. Avalia&#x000e7;&#x000e3;o
microbiol&#x000f3;gica dos aparelhos celulares de profissionais do Bloco
Cir&#x000fa;rgico em um Hospital beneficente. Rev Epidemiol Control Infecc.
2016;6(3): 120-4. doi:HYPERLINK "<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17058/reci.v6i3.6717">https://doi.org/10.17058/reci.v6i3.6717</ext-link>"
10.17058/reci.v6i3.6717</p><p>9. Conselho Regional de Enfermagem de Santa Catarina (COREN). Parecer Coren/SC n.
005/CT/2015. Assunto: Uso de aparelho celular no ambiente hospitalar [Internet].
Florianopolis (SC): Coren; 2016 [cited 2019 Feb 24]. 4 p. Available from:
<ext-link ext-link-type="uri" xlink:href="http://www.corensc.gov.br/wp-content/uploads/2016/08/Parecer-T&#x000e9;cnico-005-2016-Uso-de-aparelho-celular-no-ambiente-hospitalar.pdf">http://www.corensc.gov.br/wp-content/uploads/2016/08/Parecer-T&#x000e9;cnico-005-2016-Uso-de-aparelho-celular-no-ambiente-hospitalar.pdf</ext-link></p><p>10. Wadhera RK, Parker SH, Burkhart HM, Greason KL, Neal JR, Levenick KM, et al.
Is the "sterile cockpit" concept applicable to cardiovascular surgery critical
intervals or critical events? The impact of protocol-driven communication during
cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2010 Feb;139(2):312-9. doi:
10.1016/j.jtcvs.2009.10.048.</p><p>11. Whyte S, Cartmill C, Gardezi F, Reznick R, Orser BA, Doran D, Lingard L.
Uptake of a team briefing in the operating theatre: a Burkean dramatistic
analysis. Soc Sci Med. 2009 Dec;69(12):1757-66. Doi:
10.1016/j.socscimed.2009.09.054</p><p>12. de Vries EN, Prins HA, Crolla RM, den Outer AJ, van Andel G, van Helden SH,
et al. Effect of a comprehensive surgical safety system on patient outcomes. N
Engl J Med. 2010 Nov 11;363(20):1928-37. doi: 10.1056/NEJMsa0911535.</p><p>13. Minist&#x000e9;rio da Sa&#x000fa;de (MS), Ag&#x000ea;ncia Nacional de
Vigil&#x000e2;ncia Sanit&#x000e1;ria (ANVISA). Resolu&#x000e7;ao RDC n. 302, de 13
de outubro de 2005. Disp&#x000f5;e sobre Regulamento T&#x000e9;cnico para
funcionamento de Laborat&#x000f3;rios Cl&#x000ed;nicos [Internet].
Bras&#x000ed;lia: Republica Federativa do Brasil; 2005 [cited 2019 Feb 24]. Out
14; 2005. Available from: <ext-link ext-link-type="uri" xlink:href="http://portal.anvisa.gov.br/documents/10181/2718376/RDC_302_2005_COMP.pdf/7038e853-afae-4729-948b-ef6eb3931b19">http://portal.anvisa.gov.br/documents/10181/2718376/RDC_302_2005_COMP.pdf/7038e853-afae-4729-948b-ef6eb3931b19</ext-link></p><p>14. Society of Thoracic Surgeons Blood Conservation Guideline Task Force,
Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, Song HK,
Clough ER; Society of Cardiovascular Anesthesiologists Special Task Force on
Blood Transfusion, Shore-Lesserson LJ, Goodnough LT, Mazer CD, Shander A,
Stafford-Smith M, Waters J; International Consortium for Evidence Based
Perfusion, Baker RA, Dickinson TA, FitzGerald DJ, Likosky DS, Shann KG. 2011
update to the Society of Thoracic Surgeons and the Society of Cardiovascular
Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac
Surg. 2011 Mar;91(3):944-82. doi: 10.1016/j.athoracsur.2010.11.078.</p><p>15. Nichols JH, editor. Evidence-based practice for point-of-care testing
[Internet]. Whashigton (DC): AACC; 2006 [cited 2019 Feb 24]. 203 p. Available
from: <ext-link ext-link-type="uri" xlink:href="https://www.aacc.org/SiteCollectionDocuments/NACB/LMPG/POCT/POCT%20Entire%20LMPG.pdf">https://www.aacc.org/SiteCollectionDocuments/NACB/LMPG/POCT/POCT%20Entire%20LMPG.pdf</ext-link></p><p>16. de Somer F, Mulholland JW, Bryan MR, Aloisio T, Van Nooten GJ, Ranucci M. O2
delivery and CO2 production during cardiopulmonary bypass as determinants of
acute kidney injury: time for a goal-directed perfusion management? Crit Care.
2011 Aug 10;15(4):R192. doi: 10.1186/cc10349.</p><p>17. Warren CS, DeFoe GR, Groom RC, Pieroni JW, Groski CS, Morse CB, et al.
Variation in arterial inflow temperature: a regional quality improvement
project. J Extra Corpor Technol. 2011 Jun;43(2):58-63.</p><p>18. Baker RA, Newland RF, Fenton C, McDonald M, Willcox TW, Merry AF; Perfusion
Downunder Collaboration. Developing a benchmarking process in perfusion: a
report of the Perfusion Downunder Collaboration. J Extra Corpor Technol. 2012
Mar;44(1):26-33.</p><p>19. Asociaci&#x000f3;n Espa&#x000f1;ola de Perfusionistas (AEP). Manual de Calidad
em Perfusi&#x000f3;n [Internet]. Madrid: Asociaci&#x000f3;n Espa&#x000f1;ola de
Perfusionistas (AEP); [date unknwon] [cited 2019 Feb 24]. 27 p. Available from:
<ext-link ext-link-type="uri" xlink:href="https://www.aep.es/comisiondocumentos/7/Manual_de_calidad.pdf">https://www.aep.es/comisiondocumentos/7/Manual_de_calidad.pdf</ext-link></p><p>20. Ag&#x000ea;ncia Nacional de Vigil&#x000e2;ncia Sanit&#x000e1;ria (ANVISA). Nota
T&#x000e9;cnica GVIMS/GGTES/ANVISA N.1/2005. Orienta&#x000e7;&#x000f5;es gerais
para a notifica&#x000e7;&#x000e3;o de eventos adversos relacionados &#x000e0;
assist&#x000ea;ncia &#x000e0; assist&#x000ea;ncia &#x000e0; sa&#x000fa;de. Revisada
28 de Agosto de 2018. [Internet]. Bras&#x000ed;lia: ANVISA; 2018 [cited 2019 Feb
24]. 37 p. Available from: <ext-link ext-link-type="uri" xlink:href="https://www20.anvisa.gov.br/segurancadopaciente/index.php/alertas?task=callelement&#x00026;format=raw&#x00026;item_id=419&#x00026;element=a94a4264-a31c-42d6-91d7-464889cc6e50&#x00026;method=download">https://www20.anvisa.gov.br/segurancadopaciente/index.php/alertas?task=callelement&#x00026;format=raw&#x00026;item_id=419&#x00026;element=a94a4264-a31c-42d6-91d7-464889cc6e50&#x00026;method=download</ext-link></p><p>21. Ministerio da Sa&#x000fa;de (MS), Ag&#x000ea;ncia Nacional de Vigil&#x000e2;ncia
Sanit&#x000e1;ria (ANVISA). Resolu&#x000e7;&#x000e3;o de Direotria Colegiada - RDC
n. 2, de 24 de janeiro de 2010. Disp&#x000f5;e sobre o gerenciamento de
tecnologias em sa&#x000fa;de em estabelecimentos em sa&#x000fa;de [Internet].
Brasilia: Republica Federativa do Brasil; 2010 [cited 2019 Feb 24]. Jan 26.
Available from: <ext-link ext-link-type="uri" xlink:href="http://portal.anvisa.gov.br/documents/10181/2718376/RDC_02_2010_COMP.pdf/0a8661c8-9323-4747-b103-6e83c4ff41cd">http://portal.anvisa.gov.br/documents/10181/2718376/RDC_02_2010_COMP.pdf/0a8661c8-9323-4747-b103-6e83c4ff41cd</ext-link></p><p>22. Lipschultz A. Environment of Care Essentials for Health Care. Biomed Instruct
Technol. 2012;46(5):384.</p><p>23. The Society of Clinical Perfusion Scientists of Great Britain and Ireland,
The College of Clinical Perfusion Scientists of Great Britain and Ireland.
Standards of Practice Document. Standards of practice document [Internet].
London: The Society of Clinical Perfusion Scientists of Great Britain &#x00026;
Ireland; c 2018. Available from: HYPERLINK "<ext-link ext-link-type="uri" xlink:href="http://www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40">http://www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40</ext-link>"<ext-link ext-link-type="uri" xlink:href="http://www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40">www.scps.org.uk/index.php?option=com_content&#x00026;task=view&#x00026;id=25&#x00026;Itemid=40</ext-link>.</p><p>24. Accreditation Council for Graduate Medical Education (ACGME). Policies and
procedures [Internet]. Chicago (IL): ACGME; Sep 29, 2018 [cited 2019 Feb 24].
Available at: <ext-link ext-link-type="uri" xlink:href="https://www.acgme.org/Portals/0/PDFs/ab_ACGMEPoliciesProcedures.pdf">https://www.acgme.org/Portals/0/PDFs/ab_ACGMEPoliciesProcedures.pdf</ext-link></p><p>*Nota: "SBCCV/SBCEC Padr&#x000f5;es e Diretrizes Abrangentes para a Pr&#x000e1;tica
de Perfus&#x000e3;o no Brasil" foram baseados e adaptados da
publica&#x000e7;&#x000e3;o "The American Society of ExtraCorporeal Technology
(AmSECT) Standards and Guidelines[2] e traduzidos para o portugu&#x000ea;s.</p></app><app id="app11"><title>Appendix A (Portuguese version)</title><p><bold>Informa&#x000e7;&#x000e3;o do paciente</bold></p><list list-type="order"><list-item><p>N&#x000fa;mero do registro m&#x000e9;dico</p></list-item><list-item><p>Nome e sobrenome do paciente</p></list-item><list-item><p>Dados demogr&#x000e1;ficos:</p><p>
<list list-type="alpha-lower"><list-item><p>Idade (data de nascimento)</p></list-item><list-item><p>Sexo</p></list-item><list-item><p>Altura</p></list-item><list-item><p>Peso</p></list-item><list-item><p>Superf&#x000ed;cie corp&#x000f3;rea (SC)</p></list-item></list>
</p></list-item><list-item><p>Tipo sangu&#x000ed;neo</p></list-item><list-item><p>Dados laboratoriais:</p><p>
<list list-type="alpha-lower"><list-item><p>Hemoglobina/hemat&#x000f3;crito</p></list-item><list-item><p>Hemat&#x000f3;crito predito em CEC</p></list-item><list-item><p>Leuc&#x000f3;citos</p></list-item><list-item><p>Contagem de plaquetas</p></list-item><list-item><p>Tempo de protrombina parcial ativada (TTPa)</p></list-item><list-item><p>S&#x000f3;dio</p></list-item><list-item><p>Pot&#x000e1;ssio</p></list-item><list-item><p>Ureia/creatinina</p></list-item><list-item><p>Glicemia</p></list-item><list-item><p>Outros valores laboratoriais relevantes</p></list-item></list>
</p></list-item><list-item><p>Alergias do paciente</p></list-item><list-item><p>Procedimento cir&#x000fa;rgico planejado</p></list-item><list-item><p>Hist&#x000f3;ria m&#x000e9;dica e fatores de risco (recomendado):</p><p>
<list list-type="alpha-lower"><list-item><p>Cardiovascular</p></list-item><list-item><p>Pulmonar</p></list-item><list-item><p>Renal</p></list-item><list-item><p>Neurol&#x000f3;gico</p></list-item><list-item><p>Gastrointestinal/end&#x000f3;crino</p></list-item></list>
</p></list-item></list></app><app id="app12"><title>Appendix B (Portuguese version)</title><p><bold>Informa&#x000e7;&#x000f5;es b&#x000e1;sicas para descri&#x000e7;&#x000e3;o
detalhada do procedimento, pessoal (equipe) e equipamento
utilizado</bold></p><list list-type="order"><list-item><p>Data do procedimento</p></list-item><list-item><p>Tipo de procedimento</p></list-item><list-item><p>Nome do perfusionista(s)</p></list-item><list-item><p>Nome do cirurgi&#x000e3;o(&#x000f5;es)</p></list-item><list-item><p>Nome do anestesista(s)</p></list-item><list-item><p>Nome da enfermeira(s)</p></list-item><list-item><p>N&#x000fa;mero da sala de cirurgia</p></list-item><list-item><p>Coment&#x000e1;rios/eventos (recomendado)</p></list-item><list-item><p>Equipamento:</p><p>
<list list-type="alpha-lower"><list-item><p>M&#x000e1;quina de CEC</p></list-item><list-item><p><italic>Cell saver</italic> (autotransfus&#x000e3;o)</p></list-item><list-item><p>Trocador de calor (<italic>heater-cooler</italic>)</p></list-item></list>
</p><p><bold>Nota:</bold> os itens a-c s&#x000e3;o geralmente identificados (p.
ex., M&#x000e1;quina (Bomba) 1, 2, 3 etc.). Os n&#x000fa;meros de
s&#x000e9;rie de cada um dos componentes (bomba de rolete, vaporizadores,
<italic>blender</italic> etc.) devem estar documentados e arquivados
em local apropriado.</p></list-item><list-item><p>Descart&#x000e1;veis:</p><p>
<list list-type="alpha-lower"><list-item><p>Oxigenador</p></list-item><list-item><p>Reservat&#x000f3;rio de cardiotomia</p></list-item><list-item><p>Circuito de tubos e filtro arterial</p></list-item><list-item><p>Bomba centr&#x000ed;fuga</p></list-item><list-item><p>Sistema de cardioplegia</p></list-item><list-item><p>Circuito de autotransfus&#x000e3;o (<italic>cell
saver</italic>)</p></list-item><list-item><p>Hemofiltro</p></list-item><list-item><p>C&#x000e2;nulas arteriais</p></list-item><list-item><p>C&#x000e2;nulas venosas</p></list-item><list-item><p>C&#x000e2;nulas de cardioplegia</p></list-item><list-item><p>Aspiradores e vent(s)</p></list-item></list>
</p><p><bold>Nota:</bold> o fabricante, modelo, n&#x000fa;mero de s&#x000e9;rie
e/ou n&#x000fa;mero do lote devem ser documentados em cada um dos itens
(a-k) utilizados.</p></list-item></list></app><app id="app13"><title>Appendix C (Portuguese version)</title><p><bold>Par&#x000e2;metros fisiol&#x000f3;gicos do paciente e a&#x000e7;&#x000f5;es do
perfusionista documentadas com frequ&#x000ea;ncia definida pelo protocolo
Institucional</bold></p><list list-type="order"><list-item><p>Fluxo sangu&#x000ed;neo de perfus&#x000e3;o (RPM)</p></list-item><list-item><p>Press&#x000e3;o arterial</p></list-item><list-item><p>Press&#x000e3;o da linha arterial</p></list-item><list-item><p>Press&#x000e3;o venosa central ou press&#x000e3;o da art&#x000e9;ria
pulmonar</p></list-item><list-item><p>Retorno venoso assistido com v&#x000e1;cuo (VAVR):</p><p>
<list list-type="alpha-lower"><list-item><p>Press&#x000e3;o do reservat&#x000f3;rio venoso/da linha
venosa</p></list-item><list-item><p>Press&#x000e3;o negativa do dispositivo de v&#x000e1;cuo</p></list-item></list>
</p></list-item><list-item><p>Gasometria arterial e venosa</p></list-item><list-item><p>Satura&#x000e7;&#x000e3;o venosa de oxig&#x000ea;nio</p></list-item><list-item><p>Temperaturas do paciente, incluindo:</p><p>
<list list-type="alpha-lower"><list-item><p>Temperatura central (ao menos)</p><p>
<list list-type="roman-upper"><list-item><p>Nasofar&#x000ed;ngea</p></list-item><list-item><p>Vesical</p></list-item><list-item><p>Esof&#x000e1;gica</p></list-item><list-item><p>Retal e/ou</p></list-item><list-item><p>Timp&#x000e2;nica</p></list-item><list-item><p>Temperatura do mioc&#x000e1;rdio (opcional)</p></list-item></list>
</p></list-item></list>
</p></list-item><list-item><p>Temperaturas da CEC:</p><p>
<list list-type="roman-upper"><list-item><p>Linha de retorno venoso</p></list-item><list-item><p>Linha arterial</p></list-item><list-item><p>Da &#x000e1;gua do trocador de calor (opcional)</p></list-item></list>
</p></list-item><list-item><p>Gases do oxigenador, incluindo fluxo de gases e
concentra&#x000e7;&#x000e3;o</p></list-item><list-item><p>Entrada de l&#x000ed;quidos (volume infundido), incluindo:</p><p>
<list list-type="alpha-lower"><list-item><p>Prime</p></list-item><list-item><p>Hemoderivados</p></list-item><list-item><p>Cristaloides</p></list-item><list-item><p>Solu&#x000e7;&#x000e3;o cardiopl&#x000e9;gica</p></list-item><list-item><p>Componentes aut&#x000f3;logos</p></list-item></list>
</p></list-item><list-item><p>Cardioplegia:</p><p>
<list list-type="roman-upper"><list-item><p>Solu&#x000e7;&#x000e3;o (propor&#x000e7;&#x000e3;o se
diferentes)</p></list-item><list-item><p>Via de administra&#x000e7;&#x000e3;o (anter&#x000f3;grada,
retr&#x000f3;grada etc.)</p></list-item><list-item><p>Fluxo</p></list-item><list-item><p>Press&#x000e3;o</p></list-item><list-item><p>Temperatura</p></list-item><list-item><p>Volume</p></list-item></list>
</p></list-item><list-item><p>Volume das perdas, incluindo:</p><p>
<list list-type="alpha-lower"><list-item><p>D&#x000e9;bito unin&#x000e1;rio</p></list-item><list-item><p>Ultrafiltrado</p></list-item></list>
</p></list-item><list-item><p>Medica&#x000e7;&#x000f5;es e/ou anest&#x000e9;sicos inalat&#x000f3;rios
administrados atrav&#x000e9;s do circuito extracorp&#x000f3;reo</p></list-item></list></app><app id="app14"><title>Appendix D (Portuguese version)</title><p><bold>Resultados dos gases sangu&#x000ed;neos, eletr&#x000f3;litos e
monitora&#x000e7;&#x000e3;o da anticogula&#x000e7;&#x000e3;o</bold></p><list list-type="order"><list-item><p>Gasometria:</p><p>
<list list-type="alpha-lower"><list-item><p>pO<sub>2</sub></p></list-item><list-item><p>pCO<sub>2</sub></p></list-item><list-item><p>pH</p></list-item><list-item><p>Excesso de bases (BE)</p></list-item><list-item><p>Bicarbonato</p></list-item><list-item><p>Satura&#x000e7;&#x000e3;o</p></list-item><list-item><p>Concentra&#x000e7;&#x000e3;o de pot&#x000e1;ssio</p></list-item><list-item><p>Concentra&#x000e7;&#x000e3;o de c&#x000e1;lcio ionizado</p></list-item><list-item><p>Concentra&#x000e7;&#x000e3;o de s&#x000f3;dio</p></list-item><list-item><p>Lactato</p></list-item><list-item><p>Glicemia</p></list-item><list-item><p>Hemoglobina/hemat&#x000f3;crito</p></list-item></list>
</p></list-item><list-item><p>Tempo de coagula&#x000e7;&#x000e3;o ativado (TCA) e/ou resultados da
concentra&#x000e7;&#x000e3;o plasm&#x000e1;tica de heparina/protamina e/ou
resultado do tromboelastograma.</p></list-item></list></app><app id="app15"><title>Appendix E (Portuguese version)</title><p><bold>Avalia&#x000e7;&#x000e3;o p&#x000f3;s-operat&#x000f3;ria dos pacientes
submetidos &#x000e0; circula&#x000e7;&#x000e3;o extracorp&#x000f3;rea</bold></p><p>
<list list-type="order"><list-item><p>Nome do paciente</p></list-item><list-item><p>N&#x000fa;mero hospitalar do paciente</p></list-item><list-item><p>Data da cirurgia</p></list-item><list-item><p>Hora de entrada na UTI</p></list-item><list-item><p>Valores de CK, CKMB e troponina de 6, 12 e 24h</p></list-item><list-item><p>Fra&#x000e7;&#x000e3;o de eje&#x000e7;&#x000e3;o no
p&#x000f3;s-operat&#x000f3;rio</p></list-item><list-item><p>Valores das drogas vasoativas utilizadas com 6, 12 e 24h</p></list-item><list-item><p>Balan&#x000e7;o h&#x000ed;drico a cada 6h, at&#x000e9; completar 48h de
UTI</p></list-item><list-item><p>Press&#x000e3;o venosa central a cada 6h, at&#x000e9; completar 48h de
UTI</p></list-item><list-item><p>Uso de hemoderivados</p></list-item><list-item><p>Tempo de extuba&#x000e7;&#x000e3;o</p></list-item><list-item><p>Data de alta da UTI</p></list-item></list>
</p></app><app id="app16"><title>Appendix F (Portuguese version)</title><p><bold>Checklist</bold></p><p>O <italic>checklist</italic> deve conferir (ao menos):</p><p>
<list list-type="bullet"><list-item><p>Integridade e funcionamento da m&#x000e1;quina de CEC e trocador de
calor.</p></list-item><list-item><p>Funcionamento dos sistemas de gases e as conex&#x000f5;es com o
oxigenador.</p></list-item><list-item><p>Identifica&#x000e7;&#x000e3;o correta do paciente.</p></list-item><list-item><p>Disponibilidade de hemoderivados.</p></list-item><list-item><p>Composi&#x000e7;&#x000e3;o do perfusato.</p></list-item><list-item><p>Composi&#x000e7;&#x000e3;o e preparo da cardioplegia.</p></list-item><list-item><p>C&#x000e2;nulas que ser&#x000e3;o utilizadas.</p></list-item><list-item><p>Todas as conex&#x000f5;es do circuito.</p></list-item><list-item><p>Calibra&#x000e7;&#x000e3;o e dire&#x000e7;&#x000e3;o dos roletes.</p></list-item><list-item><p>Calibra&#x000e7;&#x000e3;o dos sensores e alarmes de press&#x000e3;o,
fluxo e bolhas.</p></list-item><list-item><p>Calibra&#x000e7;&#x000e3;o dos sensores de press&#x000e3;o de
cardioplegia.</p></list-item><list-item><p>Calibra&#x000e7;&#x000e3;o e conex&#x000e3;o do monitor de gases.</p></list-item><list-item><p>Disponibilidade de materiais descart&#x000e1;veis e equipamentos de
emerg&#x000ea;ncia (hand crank, luz de emerg&#x000ea;ncia etc.)</p></list-item><list-item><p>Dose e administra&#x000e7;&#x000e3;o de heparina.</p></list-item><list-item><p>Resultado de TCA antes de iniciar a CEC.</p></list-item><list-item><p>Disponibilidade de f&#x000e1;rmacos, agulhas, seringas e equipos de
soro e sangue para utiliza&#x000e7;&#x000e3;o durante a CEC.</p></list-item></list>
</p></app></app-group></back></article>